Motif 257 (n=164)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A0A0C4DFX4 | None | S255 | ochoa | Snf2 related CREBBP activator protein | None |
A0A1W2PPC1 | PRR33 | S317 | ochoa | Proline rich 33 | None |
A6NEL2 | SOWAHB | S258 | ochoa | Ankyrin repeat domain-containing protein SOWAHB (Ankyrin repeat domain-containing protein 56) (Protein sosondowah homolog B) | None |
A7MCY6 | TBKBP1 | S385 | ochoa | TANK-binding kinase 1-binding protein 1 (TBK1-binding protein 1) | Adapter protein which constitutively binds TBK1 and IKBKE playing a role in antiviral innate immunity. {ECO:0000269|PubMed:21931631}. |
A8MZF0 | PRR33 | S169 | ochoa | Proline-rich protein 33 | None |
H3BNR1 | BORCS8-MEF2B | S211 | ochoa | BORCS8-MEF2B readthrough | None |
O00204 | SULT2B1 | S318 | ochoa | Sulfotransferase 2B1 (EC 2.8.2.2) (Alcohol sulfotransferase) (Hydroxysteroid sulfotransferase 2) (Sulfotransferase family 2B member 1) (Sulfotransferase family cytosolic 2B member 1) (ST2B1) | Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation. Responsible for the sulfation of cholesterol (PubMed:12145317, PubMed:19589875). Catalyzes sulfation of the 3beta-hydroxyl groups of steroids, such as, pregnenolone and dehydroepiandrosterone (DHEA) (PubMed:12145317, PubMed:16855051, PubMed:21855633, PubMed:9799594). Preferentially sulfonates cholesterol, while it also has significant activity with pregnenolone and DHEA (PubMed:12145317, PubMed:21855633). Plays a role in epidermal cholesterol metabolism and in the regulation of epidermal proliferation and differentiation (PubMed:28575648). {ECO:0000269|PubMed:12145317, ECO:0000269|PubMed:16855051, ECO:0000269|PubMed:19589875, ECO:0000269|PubMed:21855633, ECO:0000269|PubMed:28575648, ECO:0000269|PubMed:9799594}.; FUNCTION: [Isoform 2]: Sulfonates pregnenolone but not cholesterol. {ECO:0000269|PubMed:12145317}. |
O14578 | CIT | S1940 | ochoa | Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21) | Plays a role in cytokinesis. Required for KIF14 localization to the central spindle and midbody. Putative RHO/RAC effector that binds to the GTP-bound forms of RHO and RAC1. It probably binds p21 with a tighter specificity in vivo. Displays serine/threonine protein kinase activity. Plays an important role in the regulation of cytokinesis and the development of the central nervous system. Phosphorylates MYL9/MLC2. {ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:16431929, ECO:0000269|PubMed:21457715, ECO:0000269|PubMed:27453578}. |
O14654 | IRS4 | S872 | ochoa | Insulin receptor substrate 4 (IRS-4) (160 kDa phosphotyrosine protein) (py160) (Phosphoprotein of 160 kDa) (pp160) | Acts as an interface between multiple growth factor receptors possessing tyrosine kinase activity, such as insulin receptor, IGF1R and FGFR1, and a complex network of intracellular signaling molecules containing SH2 domains. Involved in the IGF1R mitogenic signaling pathway. Promotes the AKT1 signaling pathway and BAD phosphorylation during insulin stimulation without activation of RPS6KB1 or the inhibition of apoptosis. Interaction with GRB2 enhances insulin-stimulated mitogen-activated protein kinase activity. May be involved in nonreceptor tyrosine kinase signaling in myoblasts. Plays a pivotal role in the proliferation/differentiation of hepatoblastoma cell through EPHB2 activation upon IGF1 stimulation. May play a role in the signal transduction in response to insulin and to a lesser extent in response to IL4 and GH on mitogenesis. Plays a role in growth, reproduction and glucose homeostasis. May act as negative regulators of the IGF1 signaling pathway by suppressing the function of IRS1 and IRS2. {ECO:0000269|PubMed:10531310, ECO:0000269|PubMed:10594015, ECO:0000269|PubMed:12639902, ECO:0000269|PubMed:17408801, ECO:0000269|PubMed:9553137}. |
O14733 | MAP2K7 | S61 | ochoa | Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2) | Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by pro-inflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Part of a non-canonical MAPK signaling pathway, composed of the upstream MAP3K12 kinase and downstream MAP kinases MAPK1/ERK2 and MAPK3/ERK1, that enhances the AP-1-mediated transcription of APP in response to APOE (PubMed:28111074). {ECO:0000269|PubMed:28111074, ECO:0000269|PubMed:9312068, ECO:0000269|PubMed:9372971, ECO:0000269|PubMed:9535930, ECO:0000269|Ref.5}. |
O15297 | PPM1D | S85 | ochoa|psp | Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1) | Involved in the negative regulation of p53 expression (PubMed:23242139). Required for the relief of p53-dependent checkpoint mediated cell cycle arrest. Binds to and dephosphorylates 'Ser-15' of TP53 and 'Ser-345' of CHEK1 which contributes to the functional inactivation of these proteins (PubMed:15870257, PubMed:16311512). Mediates MAPK14 dephosphorylation and inactivation (PubMed:21283629). Is also an important regulator of global heterochromatin silencing and critical in maintaining genome integrity (By similarity). {ECO:0000250|UniProtKB:Q9QZ67, ECO:0000269|PubMed:15870257, ECO:0000269|PubMed:16311512, ECO:0000269|PubMed:21283629, ECO:0000269|PubMed:23242139}. |
O43295 | SRGAP3 | S874 | ochoa | SLIT-ROBO Rho GTPase-activating protein 3 (srGAP3) (Mental disorder-associated GAP) (Rho GTPase-activating protein 14) (WAVE-associated Rac GTPase-activating protein) (WRP) | GTPase-activating protein for RAC1 and perhaps Cdc42, but not for RhoA small GTPase. May attenuate RAC1 signaling in neurons. {ECO:0000269|PubMed:12195014, ECO:0000269|PubMed:12447388}. |
O43516 | WIPF1 | S244 | ochoa | WAS/WASL-interacting protein family member 1 (Protein PRPL-2) (Wiskott-Aldrich syndrome protein-interacting protein) (WASP-interacting protein) | Plays a role in the reorganization of the actin cytoskeleton. Contributes with NCK1 and GRB2 in the recruitment and activation of WASL. May participate in regulating the subcellular localization of WASL, resulting in the disassembly of stress fibers in favor of filopodia formation. Plays a role in the formation of cell ruffles (By similarity). Plays an important role in the intracellular motility of vaccinia virus by functioning as an adapter for recruiting WASL to vaccinia virus. {ECO:0000250, ECO:0000269|PubMed:10878810, ECO:0000269|PubMed:19910490, ECO:0000269|PubMed:9405671}. |
O43524 | FOXO3 | S43 | ochoa | Forkhead box protein O3 (AF6q21 protein) (Forkhead in rhabdomyosarcoma-like 1) | Transcriptional activator that recognizes and binds to the DNA sequence 5'-[AG]TAAA[TC]A-3' and regulates different processes, such as apoptosis and autophagy (PubMed:10102273, PubMed:16751106, PubMed:21329882, PubMed:30513302). Acts as a positive regulator of autophagy in skeletal muscle: in starved cells, enters the nucleus following dephosphorylation and binds the promoters of autophagy genes, such as GABARAP1L, MAP1LC3B and ATG12, thereby activating their expression, resulting in proteolysis of skeletal muscle proteins (By similarity). Triggers apoptosis in the absence of survival factors, including neuronal cell death upon oxidative stress (PubMed:10102273, PubMed:16751106). Participates in post-transcriptional regulation of MYC: following phosphorylation by MAPKAPK5, promotes induction of miR-34b and miR-34c expression, 2 post-transcriptional regulators of MYC that bind to the 3'UTR of MYC transcript and prevent its translation (PubMed:21329882). In response to metabolic stress, translocates into the mitochondria where it promotes mtDNA transcription (PubMed:23283301). In response to metabolic stress, translocates into the mitochondria where it promotes mtDNA transcription. Also acts as a key regulator of chondrogenic commitment of skeletal progenitor cells in response to lipid availability: when lipids levels are low, translocates to the nucleus and promotes expression of SOX9, which induces chondrogenic commitment and suppresses fatty acid oxidation (By similarity). Also acts as a key regulator of regulatory T-cells (Treg) differentiation by activating expression of FOXP3 (PubMed:30513302). {ECO:0000250|UniProtKB:Q9WVH4, ECO:0000269|PubMed:10102273, ECO:0000269|PubMed:16751106, ECO:0000269|PubMed:21329882, ECO:0000269|PubMed:23283301, ECO:0000269|PubMed:30513302}. |
O60244 | MED14 | S1142 | ochoa | Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component) (ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog) (hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component) (DRIP150) | Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. {ECO:0000269|PubMed:15340088, ECO:0000269|PubMed:15625066, ECO:0000269|PubMed:16595664}. |
O75112 | LDB3 | S129 | ochoa | LIM domain-binding protein 3 (Protein cypher) (Z-band alternatively spliced PDZ-motif protein) | May function as an adapter in striated muscle to couple protein kinase C-mediated signaling via its LIM domains to the cytoskeleton. {ECO:0000305}. |
O75362 | ZNF217 | S848 | ochoa | Zinc finger protein 217 | Binds to the promoters of target genes and functions as repressor. Promotes cell proliferation and antagonizes cell death. Promotes phosphorylation of AKT1 at 'Ser-473'. {ECO:0000269|PubMed:16203743, ECO:0000269|PubMed:16940172, ECO:0000269|PubMed:17259635, ECO:0000269|PubMed:18625718}. |
O75665 | OFD1 | S669 | ochoa | Centriole and centriolar satellite protein OFD1 (Oral-facial-digital syndrome 1 protein) (Protein 71-7A) | Component of the centrioles controlling mother and daughter centrioles length. Recruits to the centriole IFT88 and centriole distal appendage-specific proteins including CEP164 (By similarity). Involved in the biogenesis of the cilium, a centriole-associated function. The cilium is a cell surface projection found in many vertebrate cells required to transduce signals important for development and tissue homeostasis (PubMed:33934390). Plays an important role in development by regulating Wnt signaling and the specification of the left-right axis. Only OFD1 localized at the centriolar satellites is removed by autophagy, which is an important step in the ciliogenesis regulation (By similarity). {ECO:0000250|UniProtKB:Q80Z25, ECO:0000269|PubMed:33934390}. |
O94819 | KBTBD11 | S93 | ochoa | Kelch repeat and BTB domain-containing protein 11 (Chronic myelogenous leukemia-associated protein) (Kelch domain-containing protein 7B) | None |
O95343 | SIX3 | S302 | ochoa | Homeobox protein SIX3 (Sine oculis homeobox homolog 3) | Transcriptional regulator which can act as both a transcriptional repressor and activator by binding a ATTA homeodomain core recognition sequence on these target genes. During forebrain development represses WNT1 expression allowing zona limitans intrathalamica formation and thereby ensuring proper anterio-posterior patterning of the diencephalon and formation of the rostral diencephalon. Acts as a direct upstream activator of SHH expression in the rostral diencephalon ventral midline and that in turn SHH maintains its expression. In addition, Six3 activity is required for the formation of the telencephalon. During postnatal stages of brain development is necessary for ependymal cell maturation by promoting the maturation of radial glia into ependymal cells through regulation of neuroblast proliferation and migration. Acts on the proliferation and differentiation of neural progenitor cells through activating transcription of CCND1 and CCND2. During early lens formation plays a role in lens induction and specification by activating directly PAX6 in the presumptive lens ectoderm. In turn PAX6 activates SIX3 resulting in activation of PDGFRA and CCND1 promoting cell proliferation. Also is required for the neuroretina development by directly suppressing WNT8B expression in the anterior neural plate territory. Its action during retina development and lens morphogenesis is TLE5 and TLE4-dependent manner. Furthermore, during eye development regulates several genes expression. Before and during early lens development represses the CRYGF promoter by binding a SIX repressor element. Directly activates RHO transcription, or cooperates with CRX or NRL. Six3 also functions in the formation of the proximodistal axis of the optic cup, and promotes the formation of optic vesicles-like structures. During pituitary development, acts in parallel or alternatively with HESX1 to control cell proliferation through Wnt/beta-catenin pathway (By similarity). Plays a role in eye development by suppressing WNT1 expression and in dorsal-ventral patterning by repressing BMP signaling pathway. {ECO:0000250|UniProtKB:Q62233, ECO:0000269|PubMed:18791198}. |
O95644 | NFATC1 | S409 | psp | Nuclear factor of activated T-cells, cytoplasmic 1 (NF-ATc1) (NFATc1) (NFAT transcription complex cytosolic component) (NF-ATc) (NFATc) | Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2 or IL-4 gene transcription. Also controls gene expression in embryonic cardiac cells. Could regulate not only the activation and proliferation but also the differentiation and programmed death of T-lymphocytes as well as lymphoid and non-lymphoid cells (PubMed:10358178). Required for osteoclastogenesis and regulates many genes important for osteoclast differentiation and function (By similarity). {ECO:0000250|UniProtKB:O88942, ECO:0000269|PubMed:10358178}. |
P03372 | ESR1 | S104 | psp | Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) | Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3 (PubMed:17922032). Maintains neuronal survival in response to ischemic reperfusion injury when in the presence of circulating estradiol (17-beta-estradiol/E2) (By similarity). {ECO:0000250|UniProtKB:P06211, ECO:0000269|PubMed:10681512, ECO:0000269|PubMed:10816575, ECO:0000269|PubMed:11477071, ECO:0000269|PubMed:11682626, ECO:0000269|PubMed:14764652, ECO:0000269|PubMed:15078875, ECO:0000269|PubMed:15891768, ECO:0000269|PubMed:16043358, ECO:0000269|PubMed:16617102, ECO:0000269|PubMed:16684779, ECO:0000269|PubMed:17922032, ECO:0000269|PubMed:17932106, ECO:0000269|PubMed:18247370, ECO:0000269|PubMed:19350539, ECO:0000269|PubMed:20074560, ECO:0000269|PubMed:20705611, ECO:0000269|PubMed:21330404, ECO:0000269|PubMed:22083956, ECO:0000269|PubMed:37478846, ECO:0000269|PubMed:7651415, ECO:0000269|PubMed:9328340}.; FUNCTION: [Isoform 3]: Involved in activation of NOS3 and endothelial nitric oxide production (PubMed:21937726). Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full-length receptor (PubMed:10970861). Binds to ERE and inhibits isoform 1 (PubMed:10970861). {ECO:0000269|PubMed:10970861, ECO:0000269|PubMed:21937726}. |
P08651 | NFIC | S470 | ochoa | Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein) | Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. |
P10588 | NR2F6 | S40 | ochoa | Nuclear receptor subfamily 2 group F member 6 (V-erbA-related protein 2) (EAR-2) | Transcription factor predominantly involved in transcriptional repression. Binds to promoter/enhancer response elements that contain the imperfect 5'-AGGTCA-3' direct or inverted repeats with various spacings which are also recognized by other nuclear hormone receptors. Involved in modulation of hormonal responses. Represses transcriptional activity of the lutropin-choriogonadotropic hormone receptor/LHCGR gene, the renin/REN gene and the oxytocin-neurophysin/OXT gene. Represses the triiodothyronine-dependent and -independent transcriptional activity of the thyroid hormone receptor gene in a cell type-specific manner. The corepressing function towards thyroid hormone receptor beta/THRB involves at least in part the inhibition of THRB binding to triiodothyronine response elements (TREs) by NR2F6. Inhibits NFATC transcription factor DNA binding and subsequently its transcriptional activity. Acts as transcriptional repressor of IL-17 expression in Th-17 differentiated CD4(+) T cells and may be involved in induction and/or maintenance of peripheral immunological tolerance and autoimmunity. Involved in development of forebrain circadian clock; is required early in the development of the locus coeruleus (LC). {ECO:0000269|PubMed:10644740, ECO:0000269|PubMed:10713182, ECO:0000269|PubMed:11682620, ECO:0000269|PubMed:18701084}. |
P10636 | MAPT | S238 | ochoa | Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) | Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed:21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed:21985311, PubMed:32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization. {ECO:0000269|PubMed:21985311, ECO:0000269|PubMed:32961270}. |
P12270 | TPR | S2073 | ochoa|psp | Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) | Component of the nuclear pore complex (NPC), a complex required for the trafficking across the nuclear envelope. Functions as a scaffolding element in the nuclear phase of the NPC essential for normal nucleocytoplasmic transport of proteins and mRNAs, plays a role in the establishment of nuclear-peripheral chromatin compartmentalization in interphase, and in the mitotic spindle checkpoint signaling during mitosis. Involved in the quality control and retention of unspliced mRNAs in the nucleus; in association with NUP153, regulates the nuclear export of unspliced mRNA species bearing constitutive transport element (CTE) in a NXF1- and KHDRBS1-independent manner. Negatively regulates both the association of CTE-containing mRNA with large polyribosomes and translation initiation. Does not play any role in Rev response element (RRE)-mediated export of unspliced mRNAs. Implicated in nuclear export of mRNAs transcribed from heat shock gene promoters; associates both with chromatin in the HSP70 promoter and with mRNAs transcribed from this promoter under stress-induced conditions. Modulates the nucleocytoplasmic transport of activated MAPK1/ERK2 and huntingtin/HTT and may serve as a docking site for the XPO1/CRM1-mediated nuclear export complex. According to some authors, plays a limited role in the regulation of nuclear protein export (PubMed:11952838, PubMed:22253824). Also plays a role as a structural and functional element of the perinuclear chromatin distribution; involved in the formation and/or maintenance of NPC-associated perinuclear heterochromatin exclusion zones (HEZs). Finally, acts as a spatial regulator of the spindle-assembly checkpoint (SAC) response ensuring a timely and effective recruitment of spindle checkpoint proteins like MAD1L1 and MAD2L1 to unattached kinetochore during the metaphase-anaphase transition before chromosome congression. Its N-terminus is involved in activation of oncogenic kinases. {ECO:0000269|PubMed:11952838, ECO:0000269|PubMed:15654337, ECO:0000269|PubMed:17897941, ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:18981471, ECO:0000269|PubMed:19273613, ECO:0000269|PubMed:20133940, ECO:0000269|PubMed:20407419, ECO:0000269|PubMed:21613532, ECO:0000269|PubMed:22253824, ECO:0000269|PubMed:9864356}. |
P14859 | POU2F1 | S448 | ochoa | POU domain, class 2, transcription factor 1 (NF-A1) (Octamer-binding protein 1) (Oct-1) (Octamer-binding transcription factor 1) (OTF-1) | Transcription factor that binds to the octamer motif (5'-ATTTGCAT-3') and activates the promoters of the genes for some small nuclear RNAs (snRNA) and of genes such as those for histone H2B and immunoglobulins. Modulates transcription transactivation by NR3C1, AR and PGR. {ECO:0000269|PubMed:10480874, ECO:0000269|PubMed:1684878, ECO:0000269|PubMed:7859290}.; FUNCTION: (Microbial infection) In case of human herpes simplex virus (HSV) infection, POU2F1 forms a multiprotein-DNA complex with the viral transactivator protein VP16 and HCFC1 thereby enabling the transcription of the viral immediate early genes. {ECO:0000305|PubMed:12826401}. |
P15407 | FOSL1 | S191 | ochoa | Fos-related antigen 1 (FRA-1) | None |
P15927 | RPA2 | S29 | ochoa|psp | Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) | As part of the heterotrimeric replication protein A complex (RPA/RP-A), binds and stabilizes single-stranded DNA intermediates that form during DNA replication or upon DNA stress. It prevents their reannealing and in parallel, recruits and activates different proteins and complexes involved in DNA metabolism. Thereby, it plays an essential role both in DNA replication and the cellular response to DNA damage. In the cellular response to DNA damage, the RPA complex controls DNA repair and DNA damage checkpoint activation. Through recruitment of ATRIP activates the ATR kinase a master regulator of the DNA damage response. It is required for the recruitment of the DNA double-strand break repair factors RAD51 and RAD52 to chromatin in response to DNA damage. Also recruits to sites of DNA damage proteins like XPA and XPG that are involved in nucleotide excision repair and is required for this mechanism of DNA repair. Also plays a role in base excision repair (BER) probably through interaction with UNG. Also recruits SMARCAL1/HARP, which is involved in replication fork restart, to sites of DNA damage. May also play a role in telomere maintenance. RPA stimulates 5'-3' helicase activity of BRIP1/FANCJ (PubMed:17596542). {ECO:0000269|PubMed:15205463, ECO:0000269|PubMed:17596542, ECO:0000269|PubMed:17765923, ECO:0000269|PubMed:17959650, ECO:0000269|PubMed:19116208, ECO:0000269|PubMed:20154705, ECO:0000269|PubMed:21504906, ECO:0000269|PubMed:2406247, ECO:0000269|PubMed:24332808, ECO:0000269|PubMed:7697716, ECO:0000269|PubMed:7700386, ECO:0000269|PubMed:8702565, ECO:0000269|PubMed:9430682, ECO:0000269|PubMed:9765279}. |
P17302 | GJA1 | S279 | ochoa|psp | Gap junction alpha-1 protein (Connexin-43) (Cx43) (Gap junction 43 kDa heart protein) | Gap junction protein that acts as a regulator of bladder capacity. A gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. May play a critical role in the physiology of hearing by participating in the recycling of potassium to the cochlear endolymph. Negative regulator of bladder functional capacity: acts by enhancing intercellular electrical and chemical transmission, thus sensitizing bladder muscles to cholinergic neural stimuli and causing them to contract (By similarity). May play a role in cell growth inhibition through the regulation of NOV expression and localization. Plays an essential role in gap junction communication in the ventricles (By similarity). {ECO:0000250|UniProtKB:P08050, ECO:0000250|UniProtKB:P23242}. |
P17931 | LGALS3 | Y79 | psp | Galectin-3 (Gal-3) (35 kDa lectin) (Carbohydrate-binding protein 35) (CBP 35) (Galactose-specific lectin 3) (Galactoside-binding protein) (GALBP) (IgE-binding protein) (L-31) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen) | Galactose-specific lectin which binds IgE. May mediate with the alpha-3, beta-1 integrin the stimulation by CSPG4 of endothelial cells migration. Together with DMBT1, required for terminal differentiation of columnar epithelial cells during early embryogenesis (By similarity). In the nucleus: acts as a pre-mRNA splicing factor. Involved in acute inflammatory responses including neutrophil activation and adhesion, chemoattraction of monocytes macrophages, opsonization of apoptotic neutrophils, and activation of mast cells. Together with TRIM16, coordinates the recognition of membrane damage with mobilization of the core autophagy regulators ATG16L1 and BECN1 in response to damaged endomembranes. {ECO:0000250, ECO:0000269|PubMed:15181153, ECO:0000269|PubMed:19594635, ECO:0000269|PubMed:19616076, ECO:0000269|PubMed:27693506}. |
P32927 | CSF2RB | S665 | ochoa | Cytokine receptor common subunit beta (CDw131) (GM-CSF/IL-3/IL-5 receptor common beta subunit) (CD antigen CD131) | Cell surface receptor that plays a role in immune response and controls the production and differentiation of hematopoietic progenitor cells into lineage-restricted cells. Acts by forming an heterodimeric receptor through interaction with different partners such as IL3RA, IL5RA or CSF2RA (PubMed:1495999). In turn, participates in various signaling pathways including interleukin-3, interleukin-5 and granulocyte-macrophage colony-stimulating factor/CSF2 pathways. In unstimulated conditions, interacts constitutively with JAK1 and ligand binding leads to JAK1 stimulation and subsequent activation of the JAK-STAT pathway (PubMed:9516124). {ECO:0000269|PubMed:1495999, ECO:0000269|PubMed:9516124}. |
P42694 | HELZ | T1163 | ochoa | Probable helicase with zinc finger domain (EC 3.6.4.-) (Down-regulated in human cancers protein) | May act as a helicase that plays a role in RNA metabolism in multiple tissues and organs within the developing embryo. |
P42695 | NCAPD3 | S1329 | ochoa | Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3) (hCAP-D3) | Regulatory subunit of the condensin-2 complex, a complex which establishes mitotic chromosome architecture and is involved in physical rigidity of the chromatid axis (PubMed:14532007). May promote the resolution of double-strand DNA catenanes (intertwines) between sister chromatids. Condensin-mediated compaction likely increases tension in catenated sister chromatids, providing directionality for type II topoisomerase-mediated strand exchanges toward chromatid decatenation. Specifically required for decatenation of centromeric ultrafine DNA bridges during anaphase. Early in neurogenesis, may play an essential role to ensure accurate mitotic chromosome condensation in neuron stem cells, ultimately affecting neuron pool and cortex size (PubMed:27737959). {ECO:0000269|PubMed:14532007, ECO:0000269|PubMed:27737959}. |
P46109 | CRKL | S222 | ochoa | Crk-like protein | May mediate the transduction of intracellular signals. |
P48730 | CSNK1D | S356 | ochoa | Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) | Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. In balance with PP1, determines the circadian period length through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. Controls PER1 and PER2 nuclear transport and degradation. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. Phosphorylates NEDD9/HEF1 (By similarity). EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. {ECO:0000250|UniProtKB:Q9DC28, ECO:0000269|PubMed:10606744, ECO:0000269|PubMed:12270943, ECO:0000269|PubMed:14761950, ECO:0000269|PubMed:16027726, ECO:0000269|PubMed:17562708, ECO:0000269|PubMed:17962809, ECO:0000269|PubMed:19043076, ECO:0000269|PubMed:20041275, ECO:0000269|PubMed:20048001, ECO:0000269|PubMed:20407760, ECO:0000269|PubMed:20637175, ECO:0000269|PubMed:20696890, ECO:0000269|PubMed:20699359, ECO:0000269|PubMed:21084295, ECO:0000269|PubMed:21422228, ECO:0000269|PubMed:23636092}. |
P51532 | SMARCA4 | S132 | ochoa | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4 (SMARCA4) (EC 3.6.4.-) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (Transcription activator BRG1) | ATPase involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner (PubMed:15075294, PubMed:29374058, PubMed:30339381, PubMed:32459350). Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating the calcium-dependent release of a repressor complex and the recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by SMARCA4-dependent recruitment of a phospho-RB1-HDAC repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves the release of HDAC1 and recruitment of CREBBP (By similarity). Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development, a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth. SMARCA4/BAF190A may promote neural stem cell self-renewal/proliferation by enhancing Notch-dependent proliferative signals, while concurrently making the neural stem cell insensitive to SHH-dependent differentiating cues (By similarity). Acts as a corepressor of ZEB1 to regulate E-cadherin transcription and is required for induction of epithelial-mesenchymal transition (EMT) by ZEB1 (PubMed:20418909). Binds via DLX1 to enhancers located in the intergenic region between DLX5 and DLX6 and this binding is stabilized by the long non-coding RNA (lncRNA) Evf2 (By similarity). Binds to RNA in a promiscuous manner (By similarity). In brown adipose tissue, involved in the regulation of thermogenic genes expression (By similarity). {ECO:0000250|UniProtKB:Q3TKT4, ECO:0000250|UniProtKB:Q8K1P7, ECO:0000269|PubMed:15075294, ECO:0000269|PubMed:19571879, ECO:0000269|PubMed:20418909, ECO:0000269|PubMed:29374058, ECO:0000269|PubMed:30339381, ECO:0000269|PubMed:32459350, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}. |
P52824 | DGKQ | S26 | ochoa | Diacylglycerol kinase theta (DAG kinase theta) (DGKtheta) (EC 2.7.1.107) (EC 2.7.1.93) (Diglyceride kinase theta) (DGK-theta) | Diacylglycerol kinase that converts diacylglycerol/DAG into phosphatidic acid/phosphatidate/PA and regulates the respective levels of these two bioactive lipids (PubMed:11309392, PubMed:22627129, PubMed:9099683). Thereby, acts as a central switch between the signaling pathways activated by these second messengers with different cellular targets and opposite effects in numerous biological processes (PubMed:11309392, PubMed:17664281, PubMed:26748701). Within the adrenocorticotropic hormone signaling pathway, produces phosphatidic acid which in turn activates NR5A1 and subsequent steroidogenic gene transcription (PubMed:17664281). Also functions downstream of the nerve growth factor signaling pathway being specifically activated in the nucleus by the growth factor (By similarity). Through its diacylglycerol activity also regulates synaptic vesicle endocytosis (PubMed:26748701). {ECO:0000250|UniProtKB:D3ZEY4, ECO:0000269|PubMed:11309392, ECO:0000269|PubMed:17664281, ECO:0000269|PubMed:22627129, ECO:0000269|PubMed:26748701, ECO:0000269|PubMed:9099683}. |
P55198 | MLLT6 | S429 | ochoa | Protein AF-17 (ALL1-fused gene from chromosome 17 protein) | None |
P55198 | MLLT6 | S435 | ochoa | Protein AF-17 (ALL1-fused gene from chromosome 17 protein) | None |
P78559 | MAP1A | S2629 | ochoa | Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain; MAP1 light chain LC2] | Structural protein involved in the filamentous cross-bridging between microtubules and other skeletal elements. |
Q02080 | MEF2B | S194 | ochoa | Myocyte-specific enhancer factor 2B (RSRFR2) (Serum response factor-like protein 2) | Transcriptional activator which binds specifically to the MEF2 element, 5'-YTA[AT](4)TAR-3', found in numerous muscle-specific genes. Activates transcription via this element. May be involved in muscle-specific and/or growth factor-related transcription. |
Q02952 | AKAP12 | S749 | ochoa | A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen) | Anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA) and protein kinase C (PKC). |
Q03001 | DST | S7432 | ochoa | Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) | Cytoskeletal linker protein. Acts as an integrator of intermediate filaments, actin and microtubule cytoskeleton networks. Required for anchoring either intermediate filaments to the actin cytoskeleton in neural and muscle cells or keratin-containing intermediate filaments to hemidesmosomes in epithelial cells. The proteins may self-aggregate to form filaments or a two-dimensional mesh. Regulates the organization and stability of the microtubule network of sensory neurons to allow axonal transport. Mediates docking of the dynein/dynactin motor complex to vesicle cargos for retrograde axonal transport through its interaction with TMEM108 and DCTN1 (By similarity). {ECO:0000250|UniProtKB:Q91ZU6}.; FUNCTION: [Isoform 3]: Plays a structural role in the assembly of hemidesmosomes of epithelial cells; anchors keratin-containing intermediate filaments to the inner plaque of hemidesmosomes. Required for the regulation of keratinocyte polarity and motility; mediates integrin ITGB4 regulation of RAC1 activity.; FUNCTION: [Isoform 6]: Required for bundling actin filaments around the nucleus. {ECO:0000250, ECO:0000269|PubMed:10428034, ECO:0000269|PubMed:12482924, ECO:0000269|PubMed:19403692}.; FUNCTION: [Isoform 7]: Regulates the organization and stability of the microtubule network of sensory neurons to allow axonal transport. |
Q03060 | CREM | S277 | psp | cAMP-responsive element modulator (Inducible cAMP early repressor) (ICER) | Transcriptional regulator that binds the cAMP response element (CRE), a sequence present in many viral and cellular promoters. Isoforms are either transcriptional activators or repressors. Plays a role in spermatogenesis and is involved in spermatid maturation (PubMed:10373550). {ECO:0000269|PubMed:10373550}.; FUNCTION: [Isoform 6]: May play a role in the regulation of the circadian clock: acts as a transcriptional repressor of the core circadian component PER1 by directly binding to cAMP response elements in its promoter. {ECO:0000250}. |
Q04725 | TLE2 | S193 | ochoa | Transducin-like enhancer protein 2 (Enhancer of split groucho-like protein 2) (ESG2) | Transcriptional corepressor that binds to a number of transcription factors. Inhibits the transcriptional activation mediated by CTNNB1 and TCF family members in Wnt signaling. The effects of full-length TLE family members may be modulated by association with dominant-negative AES (By similarity). {ECO:0000250}. |
Q04725 | TLE2 | S313 | ochoa | Transducin-like enhancer protein 2 (Enhancer of split groucho-like protein 2) (ESG2) | Transcriptional corepressor that binds to a number of transcription factors. Inhibits the transcriptional activation mediated by CTNNB1 and TCF family members in Wnt signaling. The effects of full-length TLE family members may be modulated by association with dominant-negative AES (By similarity). {ECO:0000250}. |
Q06587 | RING1 | S254 | ochoa | E3 ubiquitin-protein ligase RING1 (EC 2.3.2.27) (Polycomb complex protein RING1) (RING finger protein 1) (RING-type E3 ubiquitin transferase RING1) (Really interesting new gene 1 protein) | Constitutes one of the E3 ubiquitin-protein ligases that mediate monoubiquitination of 'Lys-119' of histone H2A, thereby playing a central role in histone code and gene regulation. H2A 'Lys-119' ubiquitination gives a specific tag for epigenetic transcriptional repression and participates in X chromosome inactivation of female mammals. Essential component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones, rendering chromatin heritably changed in its expressibility. Compared to RNF2/RING2, it does not have the main E3 ubiquitin ligase activity on histone H2A, and it may rather act as a modulator of RNF2/RING2 activity. {ECO:0000269|PubMed:16359901}. |
Q06945 | SOX4 | S354 | ochoa | Transcription factor SOX-4 | Transcriptional activator that binds with high affinity to the T-cell enhancer motif 5'-AACAAAG-3' motif (PubMed:30661772). Required for IL17A-producing Vgamma2-positive gamma-delta T-cell maturation and development, via binding to regulator loci of RORC to modulate expression (By similarity). Involved in skeletal myoblast differentiation by promoting gene expression of CALD1 (PubMed:26291311). {ECO:0000250|UniProtKB:Q06831, ECO:0000269|PubMed:26291311, ECO:0000269|PubMed:30661772}. |
Q10571 | MN1 | S1081 | ochoa | Transcriptional activator MN1 (Probable tumor suppressor protein MN1) | Transcriptional activator which specifically regulates expression of TBX22 in the posterior region of the developing palate. Required during later stages of palate development for growth and medial fusion of the palatal shelves. Promotes maturation and normal function of calvarial osteoblasts, including expression of the osteoclastogenic cytokine TNFSF11/RANKL. Necessary for normal development of the membranous bones of the skull (By similarity). May play a role in tumor suppression (Probable). {ECO:0000250|UniProtKB:D3YWE6, ECO:0000305|PubMed:7731706}. |
Q13428 | TCOF1 | S233 | ochoa | Treacle protein (Treacher Collins syndrome protein) | Nucleolar protein that acts as a regulator of RNA polymerase I by connecting RNA polymerase I with enzymes responsible for ribosomal processing and modification (PubMed:12777385, PubMed:26399832). Required for neural crest specification: following monoubiquitination by the BCR(KBTBD8) complex, associates with NOLC1 and acts as a platform to connect RNA polymerase I with enzymes responsible for ribosomal processing and modification, leading to remodel the translational program of differentiating cells in favor of neural crest specification (PubMed:26399832). {ECO:0000269|PubMed:12777385, ECO:0000269|PubMed:26399832}. |
Q13469 | NFATC2 | S79 | psp | Nuclear factor of activated T-cells, cytoplasmic 2 (NF-ATc2) (NFATc2) (NFAT pre-existing subunit) (NF-ATp) (T-cell transcription factor NFAT1) | Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2, IL-3, IL-4, TNF-alpha or GM-CSF (PubMed:15790681). Promotes invasive migration through the activation of GPC6 expression and WNT5A signaling pathway (PubMed:21871017). Is involved in the negative regulation of chondrogenesis (PubMed:35789258). Recruited by AKAP5 to ORAI1 pore-forming subunit of CRAC channels in Ca(2+) signaling microdomains where store-operated Ca(2+) influx is coupled to calmodulin and calcineurin signaling and activation of NFAT-dependent transcriptional responses. {ECO:0000250|UniProtKB:Q60591, ECO:0000269|PubMed:15790681, ECO:0000269|PubMed:21871017, ECO:0000269|PubMed:35789258}. |
Q14160 | SCRIB | S1547 | ochoa | Protein scribble homolog (Scribble) (hScrib) (Protein LAP4) | Scaffold protein involved in different aspects of polarized cell differentiation regulating epithelial and neuronal morphogenesis and T-cell polarization (PubMed:15182672, PubMed:16344308, PubMed:16965391, PubMed:18641685, PubMed:18716323, PubMed:19041750, PubMed:27380321). Via its interaction with CRTAM, required for the late phase polarization of a subset of CD4+ T-cells, which in turn regulates TCR-mediated proliferation and IFNG and IL22 production (By similarity). Plays a role in cell directional movement, cell orientation, cell sheet organization and Golgi complex polarization at the cell migration front (By similarity). Promotes epithelial cell layer barrier function via maintaining cell-cell adhesion (By similarity). Most probably functions in the establishment of apico-basal cell polarity (PubMed:16344308, PubMed:19041750). May function in cell proliferation regulating progression from G1 to S phase and as a positive regulator of apoptosis for instance during acinar morphogenesis of the mammary epithelium (PubMed:16965391, PubMed:19041750). May regulate cell invasion via MAPK-mediated cell migration and adhesion (PubMed:18641685, PubMed:18716323). May play a role in exocytosis and in the targeting of synaptic vesicles to synapses (PubMed:15182672). Functions as an activator of Rac GTPase activity (PubMed:15182672). {ECO:0000250|UniProtKB:A0A8P0N4K0, ECO:0000250|UniProtKB:Q80U72, ECO:0000269|PubMed:15182672, ECO:0000269|PubMed:16344308, ECO:0000269|PubMed:16965391, ECO:0000269|PubMed:18641685, ECO:0000269|PubMed:18716323, ECO:0000269|PubMed:19041750, ECO:0000269|PubMed:27380321}. |
Q14669 | TRIP12 | S1036 | ochoa | E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (E3 ubiquitin-protein ligase for Arf) (ULF) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12) | E3 ubiquitin-protein ligase involved in ubiquitin fusion degradation (UFD) pathway and regulation of DNA repair (PubMed:19028681, PubMed:22884692). Part of the ubiquitin fusion degradation (UFD) pathway, a process that mediates ubiquitination of protein at their N-terminus, regardless of the presence of lysine residues in target proteins (PubMed:19028681). Acts as a key regulator of DNA damage response by acting as a suppressor of RNF168, an E3 ubiquitin-protein ligase that promotes accumulation of 'Lys-63'-linked histone H2A and H2AX at DNA damage sites, thereby acting as a guard against excessive spreading of ubiquitinated chromatin at damaged chromosomes (PubMed:22884692). In normal cells, mediates ubiquitination and degradation of isoform p19ARF/ARF of CDKN2A, a lysine-less tumor suppressor required for p53/TP53 activation under oncogenic stress (PubMed:20208519). In cancer cells, however, isoform p19ARF/ARF and TRIP12 are located in different cell compartments, preventing isoform p19ARF/ARF ubiquitination and degradation (PubMed:20208519). Does not mediate ubiquitination of isoform p16-INK4a of CDKN2A (PubMed:20208519). Also catalyzes ubiquitination of NAE1 and SMARCE1, leading to their degradation (PubMed:18627766). Ubiquitination and degradation of target proteins is regulated by interaction with proteins such as MYC, TRADD or SMARCC1, which disrupt the interaction between TRIP12 and target proteins (PubMed:20829358). Mediates ubiquitination of ASXL1: following binding to N(6)-methyladenosine methylated DNA, ASXL1 is ubiquitinated by TRIP12, leading to its degradation and subsequent inactivation of the PR-DUB complex (PubMed:30982744). {ECO:0000269|PubMed:18627766, ECO:0000269|PubMed:19028681, ECO:0000269|PubMed:20208519, ECO:0000269|PubMed:20829358, ECO:0000269|PubMed:22884692, ECO:0000269|PubMed:30982744}. |
Q14676 | MDC1 | S964 | ochoa | Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1) | Histone reader protein required for checkpoint-mediated cell cycle arrest in response to DNA damage within both the S phase and G2/M phases of the cell cycle (PubMed:12475977, PubMed:12499369, PubMed:12551934, PubMed:12607003, PubMed:12607004, PubMed:12607005, PubMed:12611903, PubMed:14695167, PubMed:15201865, PubMed:15377652, PubMed:16049003, PubMed:16377563, PubMed:30898438). Specifically recognizes and binds histone H2AX phosphorylated at 'Ser-139', a marker of DNA damage, serving as a scaffold for the recruitment of DNA repair and signal transduction proteins to discrete foci of DNA damage sites (PubMed:12607005, PubMed:15201865, PubMed:16049003, PubMed:16377563, PubMed:30898438). Also required for downstream events subsequent to the recruitment of these proteins (PubMed:12607005, PubMed:15201865, PubMed:16049003, PubMed:16377563, PubMed:18582474). These include phosphorylation and activation of the ATM, CHEK1 and CHEK2 kinases, and stabilization of TP53/p53 and apoptosis (PubMed:12499369, PubMed:12551934, PubMed:12607004). ATM and CHEK2 may also be activated independently by a parallel pathway mediated by TP53BP1 (PubMed:12499369, PubMed:12551934, PubMed:12607004). Required for chromosomal stability during mitosis by promoting recruitment of TOPBP1 to DNA double strand breaks (DSBs): TOPBP1 forms filamentous assemblies that bridge MDC1 and tether broken chromosomes during mitosis (PubMed:30898438). Required for the repair of DSBs via homologous recombination by promoting recruitment of NBN component of the MRN complex to DSBs (PubMed:18411307, PubMed:18582474, PubMed:18583988, PubMed:18678890). {ECO:0000269|PubMed:12475977, ECO:0000269|PubMed:12499369, ECO:0000269|PubMed:12551934, ECO:0000269|PubMed:12607003, ECO:0000269|PubMed:12607004, ECO:0000269|PubMed:12607005, ECO:0000269|PubMed:12611903, ECO:0000269|PubMed:14695167, ECO:0000269|PubMed:15201865, ECO:0000269|PubMed:15377652, ECO:0000269|PubMed:16049003, ECO:0000269|PubMed:16377563, ECO:0000269|PubMed:18411307, ECO:0000269|PubMed:18582474, ECO:0000269|PubMed:18583988, ECO:0000269|PubMed:18678890, ECO:0000269|PubMed:30898438}. |
Q14686 | NCOA6 | S1751 | ochoa | Nuclear receptor coactivator 6 (Activating signal cointegrator 2) (ASC-2) (Amplified in breast cancer protein 3) (Cancer-amplified transcriptional coactivator ASC-2) (Nuclear receptor coactivator RAP250) (NRC RAP250) (Nuclear receptor-activating protein, 250 kDa) (Peroxisome proliferator-activated receptor-interacting protein) (PPAR-interacting protein) (PRIP) (Thyroid hormone receptor-binding protein) | Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Coactivates expression in an agonist- and AF2-dependent manner. Involved in the coactivation of different nuclear receptors, such as for steroids (GR and ERs), retinoids (RARs and RXRs), thyroid hormone (TRs), vitamin D3 (VDR) and prostanoids (PPARs). Probably functions as a general coactivator, rather than just a nuclear receptor coactivator. May also be involved in the coactivation of the NF-kappa-B pathway. May coactivate expression via a remodeling of chromatin and its interaction with histone acetyltransferase proteins. |
Q14764 | MVP | S873 | ochoa | Major vault protein (MVP) (Lung resistance-related protein) | Required for normal vault structure. Vaults are multi-subunit structures that may act as scaffolds for proteins involved in signal transduction. Vaults may also play a role in nucleo-cytoplasmic transport. Down-regulates IFNG-mediated STAT1 signaling and subsequent activation of JAK. Down-regulates SRC activity and signaling through MAP kinases. {ECO:0000269|PubMed:15133037, ECO:0000269|PubMed:16418217, ECO:0000269|PubMed:16441665}. |
Q14814 | MEF2D | S251 | ochoa|psp | Myocyte-specific enhancer factor 2D | Transcriptional activator which binds specifically to the MEF2 element, 5'-YTA[AT](4)TAR-3', found in numerous muscle-specific, growth factor- and stress-induced genes. Mediates cellular functions not only in skeletal and cardiac muscle development, but also in neuronal differentiation and survival. Plays diverse roles in the control of cell growth, survival and apoptosis via p38 MAPK signaling in muscle-specific and/or growth factor-related transcription. Plays a critical role in the regulation of neuronal apoptosis (By similarity). {ECO:0000250, ECO:0000269|PubMed:10849446, ECO:0000269|PubMed:11904443, ECO:0000269|PubMed:12691662, ECO:0000269|PubMed:15743823, ECO:0000269|PubMed:15834131}. |
Q15003 | NCAPH | S28 | ochoa | Condensin complex subunit 2 (Barren homolog protein 1) (Chromosome-associated protein H) (hCAP-H) (Non-SMC condensin I complex subunit H) (XCAP-H homolog) | Regulatory subunit of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases (PubMed:11136719). Early in neurogenesis, may play an essential role to ensure accurate mitotic chromosome condensation in neuron stem cells, ultimately affecting neuron pool and cortex size (PubMed:27737959). {ECO:0000269|PubMed:11136719, ECO:0000269|PubMed:27737959}. |
Q15596 | NCOA2 | S499 | ochoa|psp | Nuclear receptor coactivator 2 (NCoA-2) (Class E basic helix-loop-helix protein 75) (bHLHe75) (Transcriptional intermediary factor 2) (hTIF2) | Transcriptional coactivator for steroid receptors and nuclear receptors (PubMed:23508108, PubMed:8670870, PubMed:9430642, PubMed:22504882, PubMed:26553876). Coactivator of the steroid binding domain (AF-2) but not of the modulating N-terminal domain (AF-1) (PubMed:23508108, PubMed:8670870, PubMed:9430642). Required with NCOA1 to control energy balance between white and brown adipose tissues (PubMed:23508108, PubMed:8670870, PubMed:9430642). Critical regulator of glucose metabolism regulation, acts as a RORA coactivator to specifically modulate G6PC1 expression (PubMed:23508108, PubMed:8670870, PubMed:9430642). Involved in the positive regulation of the transcriptional activity of the glucocorticoid receptor NR3C1 by sumoylation enhancer RWDD3 (PubMed:23508108). Positively regulates the circadian clock by acting as a transcriptional coactivator for the CLOCK-BMAL1 heterodimer (By similarity). {ECO:0000250|UniProtKB:Q61026, ECO:0000269|PubMed:22504882, ECO:0000269|PubMed:23508108, ECO:0000269|PubMed:26553876, ECO:0000269|PubMed:8670870, ECO:0000269|PubMed:9430642}. |
Q15723 | ELF2 | S430 | ochoa | ETS-related transcription factor Elf-2 (E74-like factor 2) (New ETS-related factor) | Isoform 1 transcriptionally activates the LYN and BLK promoters and acts synergistically with RUNX1 to transactivate the BLK promoter.; FUNCTION: Isoform 2 may function in repression of RUNX1-mediated transactivation. |
Q15772 | SPEG | S2177 | ochoa | Striated muscle preferentially expressed protein kinase (EC 2.7.11.1) (Aortic preferentially expressed protein 1) (APEG-1) | Isoform 3 may have a role in regulating the growth and differentiation of arterial smooth muscle cells. |
Q4L180 | FILIP1L | S1019 | ochoa | Filamin A-interacting protein 1-like (130 kDa GPBP-interacting protein) (90 kDa GPBP-interacting protein) (Protein down-regulated in ovarian cancer 1) (DOC-1) | Acts as a regulator of the antiangiogenic activity on endothelial cells. When overexpressed in endothelial cells, leads to inhibition of cell proliferation and migration and an increase in apoptosis. Inhibits melanoma growth When expressed in tumor-associated vasculature. {ECO:0000269|PubMed:18794120}. |
Q53F19 | NCBP3 | S506 | ochoa | Nuclear cap-binding protein subunit 3 (Protein ELG) | Associates with NCBP1/CBP80 to form an alternative cap-binding complex (CBC) which plays a key role in mRNA export. NCBP3 serves as adapter protein linking the capped RNAs (m7GpppG-capped RNA) to NCBP1/CBP80. Unlike the conventional CBC with NCBP2 which binds both small nuclear RNA (snRNA) and messenger (mRNA) and is involved in their export from the nucleus, the alternative CBC with NCBP3 does not bind snRNA and associates only with mRNA thereby playing a role in only mRNA export. The alternative CBC is particularly important in cellular stress situations such as virus infections and the NCBP3 activity is critical to inhibit virus growth (PubMed:26382858). {ECO:0000269|PubMed:26382858}. |
Q5JTD0 | TJAP1 | S214 | ochoa | Tight junction-associated protein 1 (Protein incorporated later into tight junctions) (Tight junction protein 4) | Plays a role in regulating the structure of the Golgi apparatus. {ECO:0000250|UniProtKB:Q9DCD5}. |
Q5VV41 | ARHGEF16 | S41 | ochoa | Rho guanine nucleotide exchange factor 16 (Ephexin-4) | Guanyl-nucleotide exchange factor of the RHOG GTPase stimulating the exchange of RHOG-associated GDP for GTP. May play a role in chemotactic cell migration by mediating the activation of RAC1 by EPHA2. May also activate CDC42 and mediate activation of CDC42 by the viral protein HPV16 E6. {ECO:0000269|PubMed:20679435}. |
Q66K14 | TBC1D9B | S420 | ochoa | TBC1 domain family member 9B | May act as a GTPase-activating protein for Rab family protein(s). |
Q66K74 | MAP1S | S632 | ochoa | Microtubule-associated protein 1S (MAP-1S) (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1) (VCY2-interacting protein 1) (VCY2IP-1) [Cleaved into: MAP1S heavy chain; MAP1S light chain] | Microtubule-associated protein that mediates aggregation of mitochondria resulting in cell death and genomic destruction (MAGD). Plays a role in anchoring the microtubule organizing center to the centrosomes. Binds to DNA. Plays a role in apoptosis. Involved in the formation of microtubule bundles (By similarity). {ECO:0000250, ECO:0000269|PubMed:15899810, ECO:0000269|PubMed:17234756}. |
Q6KC79 | NIPBL | S280 | ochoa | Nipped-B-like protein (Delangin) (SCC2 homolog) | Plays an important role in the loading of the cohesin complex on to DNA. Forms a heterodimeric complex (also known as cohesin loading complex) with MAU2/SCC4 which mediates the loading of the cohesin complex onto chromatin (PubMed:22628566, PubMed:28914604). Plays a role in cohesin loading at sites of DNA damage. Its recruitment to double-strand breaks (DSBs) sites occurs in a CBX3-, RNF8- and RNF168-dependent manner whereas its recruitment to UV irradiation-induced DNA damage sites occurs in a ATM-, ATR-, RNF8- and RNF168-dependent manner (PubMed:28167679). Along with ZNF609, promotes cortical neuron migration during brain development by regulating the transcription of crucial genes in this process. Preferentially binds promoters containing paused RNA polymerase II. Up-regulates the expression of SEMA3A, NRP1, PLXND1 and GABBR2 genes, among others (By similarity). {ECO:0000250|UniProtKB:Q6KCD5, ECO:0000269|PubMed:22628566, ECO:0000269|PubMed:28167679, ECO:0000269|PubMed:28914604}. |
Q6NUJ5 | PWWP2B | S84 | ochoa | PWWP domain-containing protein 2B | Chromatin-binding protein that acts as an adapter between distinct nucleosome components (H3K36me3 or H2A.Z) and chromatin-modifying complexes, contributing to the regulation of the levels of histone acetylation at actively transcribed genes (PubMed:30228260). Competes with CHD4 and MBD3 for interaction with MTA1 to form a NuRD subcomplex, preventing the formation of full NuRD complex (containing CHD4 and MBD3), leading to recruitment of HDACs to gene promoters resulting in turn in the deacetylation of nearby H3K27 and H2A.Z (PubMed:30228260). Plays a role in facilitating transcriptional elongation through regulation of histone acetylation (By similarity). Negatively regulates brown adipocyte thermogenesis by interacting with and stabilizing HDAC1 at the UCP1 gene promoter, thereby promoting histone deacetylation at the promoter leading to the repression of UCP1 expression (By similarity). {ECO:0000250|UniProtKB:Q69Z61, ECO:0000269|PubMed:30228260}. |
Q6NV74 | CRACDL | S646 | ochoa | CRACD-like protein | None |
Q6P2E9 | EDC4 | S780 | ochoa | Enhancer of mRNA-decapping protein 4 (Autoantigen Ge-1) (Autoantigen RCD-8) (Human enhancer of decapping large subunit) (Hedls) | In the process of mRNA degradation, seems to play a role in mRNA decapping. Component of a complex containing DCP2 and DCP1A which functions in decapping of ARE-containing mRNAs. Promotes complex formation between DCP1A and DCP2. Enhances the catalytic activity of DCP2 (in vitro). {ECO:0000269|PubMed:16364915}. |
Q6PJF5 | RHBDF2 | S177 | ochoa | Inactive rhomboid protein 2 (iRhom2) (Rhomboid 5 homolog 2) (Rhomboid family member 2) (Rhomboid veinlet-like protein 5) (Rhomboid veinlet-like protein 6) | Regulates ADAM17 protease, a sheddase of the epidermal growth factor (EGF) receptor ligands and TNF, thereby plays a role in sleep, cell survival, proliferation, migration and inflammation. Does not exhibit any protease activity on its own. {ECO:0000250|UniProtKB:Q80WQ6}. |
Q6UXY1 | BAIAP2L2 | S231 | ochoa | BAR/IMD domain-containing adapter protein 2-like 2 (Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2) (BAI1-associated protein 2-like protein 2) (Planar intestinal- and kidney-specific BAR domain protein) (Pinkbar) | Phosphoinositides-binding protein that induces the formation of planar or gently curved membrane structures. Binds to phosphoinositides, including to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) headgroups. There seems to be no clear preference for a specific phosphoinositide (By similarity). {ECO:0000250}. |
Q6ZRS2 | SRCAP | S274 | ochoa | Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator) | Catalytic component of the SRCAP complex which mediates the ATP-dependent exchange of histone H2AZ/H2B dimers for nucleosomal H2A/H2B, leading to transcriptional regulation of selected genes by chromatin remodeling. Acts as a coactivator for CREB-mediated transcription, steroid receptor-mediated transcription, and Notch-mediated transcription. {ECO:0000269|PubMed:10347196, ECO:0000269|PubMed:11522779, ECO:0000269|PubMed:14500758, ECO:0000269|PubMed:16024792, ECO:0000269|PubMed:16634648, ECO:0000269|PubMed:17617668}. |
Q6ZU65 | UBN2 | S1042 | ochoa | Ubinuclein-2 | None |
Q6ZU65 | UBN2 | S1048 | ochoa | Ubinuclein-2 | None |
Q6ZU65 | UBN2 | S1054 | ochoa | Ubinuclein-2 | None |
Q6ZVM7 | TOM1L2 | S194 | ochoa | TOM1-like protein 2 (Target of Myb-like protein 2) | Acts as a MYO6/Myosin VI adapter protein that targets myosin VI to endocytic structures (PubMed:23023224). May also play a role in recruiting clathrin to endosomes (PubMed:16412388). May regulate growth factor-induced mitogenic signaling (PubMed:16479011). {ECO:0000269|PubMed:16412388, ECO:0000269|PubMed:16479011, ECO:0000269|PubMed:23023224}. |
Q6ZW31 | SYDE1 | S66 | ochoa | Rho GTPase-activating protein SYDE1 (Synapse defective protein 1 homolog 1) (Protein syd-1 homolog 1) | GTPase activator for the Rho-type GTPases. As a GCM1 downstream effector, it is involved in placental development and positively regulates trophoblast cells migration. It regulates cytoskeletal remodeling by controlling the activity of Rho GTPases including RHOA, CDC42 and RAC1 (PubMed:27917469). {ECO:0000269|PubMed:27917469}. |
Q76NI1 | KNDC1 | S392 | ochoa | Kinase non-catalytic C-lobe domain-containing protein 1 (KIND domain-containing protein 1) (Cerebral protein 9) (Protein very KIND) (v-KIND) (Ras-GEF domain-containing family member 2) | RAS-Guanine nucleotide exchange factor (GEF) that controls the negative regulation of neuronal dendrite growth by mediating a signaling pathway linking RAS and MAP2 (By similarity). May be involved in cellular senescence (PubMed:24788352). {ECO:0000250|UniProtKB:Q0KK55, ECO:0000269|PubMed:24788352}. |
Q7L311 | ARMCX2 | S244 | ochoa | Armadillo repeat-containing X-linked protein 2 (ARM protein lost in epithelial cancers on chromosome X 2) (Protein ALEX2) | May regulate the dynamics and distribution of mitochondria in neural cells. {ECO:0000250|UniProtKB:Q6A058}. |
Q7Z2K8 | GPRIN1 | S615 | ochoa | G protein-regulated inducer of neurite outgrowth 1 (GRIN1) | May be involved in neurite outgrowth. {ECO:0000250}. |
Q7Z2Z1 | TICRR | S1352 | ochoa | Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein) | Regulator of DNA replication and S/M and G2/M checkpoints. Regulates the triggering of DNA replication initiation via its interaction with TOPBP1 by participating in CDK2-mediated loading of CDC45L onto replication origins. Required for the transition from pre-replication complex (pre-RC) to pre-initiation complex (pre-IC). Required to prevent mitotic entry after treatment with ionizing radiation. {ECO:0000269|PubMed:20116089}. |
Q7Z5J4 | RAI1 | S345 | ochoa | Retinoic acid-induced protein 1 | Transcriptional regulator of the circadian clock components: CLOCK, BMAL1, BMAL2, PER1/3, CRY1/2, NR1D1/2 and RORA/C. Positively regulates the transcriptional activity of CLOCK a core component of the circadian clock. Regulates transcription through chromatin remodeling by interacting with other proteins in chromatin as well as proteins in the basic transcriptional machinery. May be important for embryonic and postnatal development. May be involved in neuronal differentiation. {ECO:0000269|PubMed:22578325}. |
Q86VM9 | ZC3H18 | S868 | ochoa | Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1) | None |
Q8IWC1 | MAP7D3 | S322 | ochoa | MAP7 domain-containing protein 3 | Promotes the assembly and stability of microtubules. {ECO:0000269|PubMed:22142902, ECO:0000269|PubMed:24927501}. |
Q8IWZ8 | SUGP1 | S344 | ochoa | SURP and G-patch domain-containing protein 1 (RNA-binding protein RBP) (Splicing factor 4) | Plays a role in pre-mRNA splicing. |
Q8IX07 | ZFPM1 | S512 | ochoa | Zinc finger protein ZFPM1 (Friend of GATA protein 1) (FOG-1) (Friend of GATA 1) (Zinc finger protein 89A) (Zinc finger protein multitype 1) | Transcription regulator that plays an essential role in erythroid and megakaryocytic cell differentiation. Essential cofactor that acts via the formation of a heterodimer with transcription factors of the GATA family GATA1, GATA2 and GATA3. Such heterodimer can both activate or repress transcriptional activity, depending on the cell and promoter context. The heterodimer formed with GATA proteins is essential to activate expression of genes such as NFE2, ITGA2B, alpha- and beta-globin, while it represses expression of KLF1. May be involved in regulation of some genes in gonads. May also be involved in cardiac development, in a non-redundant way with ZFPM2/FOG2 (By similarity). {ECO:0000250}. |
Q8IYB3 | SRRM1 | S775 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8IZD0 | SAMD14 | S288 | ochoa | Sterile alpha motif domain-containing protein 14 (SAM domain-containing protein 14) | None |
Q8IZT6 | ASPM | S35 | ochoa | Abnormal spindle-like microcephaly-associated protein (Abnormal spindle protein homolog) (Asp homolog) | Involved in mitotic spindle regulation and coordination of mitotic processes. The function in regulating microtubule dynamics at spindle poles including spindle orientation, astral microtubule density and poleward microtubule flux seems to depend on the association with the katanin complex formed by KATNA1 and KATNB1. Enhances the microtubule lattice severing activity of KATNA1 by recruiting the katanin complex to microtubules. Can block microtubule minus-end growth and reversely this function can be enhanced by the katanin complex (PubMed:28436967). May have a preferential role in regulating neurogenesis. {ECO:0000269|PubMed:12355089, ECO:0000269|PubMed:15972725, ECO:0000269|PubMed:28436967}. |
Q8IZW8 | TNS4 | S248 | ochoa | Tensin-4 (C-terminal tensin-like protein) | Promotes EGF-induced cell migration by displacing tensin TNS3 from the cytoplasmic tail of integrin ITGB1 which results in dissociation of TNS3 from focal adhesions, disassembly of actin stress fibers and initiation of cell migration (PubMed:17643115). Suppresses ligand-induced degradation of EGFR by reducing EGFR ubiquitination in the presence of EGF (PubMed:23774213). Increases MET protein stability by inhibiting MET endocytosis and subsequent lysosomal degradation which leads to increased cell survival, proliferation and migration (PubMed:24814316). {ECO:0000269|PubMed:17643115, ECO:0000269|PubMed:23774213, ECO:0000269|PubMed:24814316}. |
Q8N3D4 | EHBP1L1 | S245 | ochoa | EH domain-binding protein 1-like protein 1 | May act as Rab effector protein and play a role in vesicle trafficking. {ECO:0000305|PubMed:27552051}. |
Q8N3V7 | SYNPO | S899 | ochoa | Synaptopodin | Actin-associated protein that may play a role in modulating actin-based shape and motility of dendritic spines and renal podocyte foot processes. Seems to be essential for the formation of spine apparatuses in spines of telencephalic neurons, which is involved in synaptic plasticity (By similarity). {ECO:0000250}. |
Q8NB15 | ZNF511 | S214 | ochoa | Zinc finger protein 511 | May be involved in transcriptional regulation. {ECO:0000305}. |
Q8NC56 | LEMD2 | S166 | ochoa | LEM domain-containing protein 2 (hLEM2) | Nuclear lamina-associated inner nuclear membrane protein that is involved in nuclear structure organization, maintenance of nuclear envelope (NE) integrity and NE reformation after mitosis (PubMed:16339967, PubMed:17097643, PubMed:28242692, PubMed:32494070). Plays a role as transmembrane adapter for the endosomal sorting complexes required for transport (ESCRT), and is thereby involved in ESCRT-mediated NE reformation (PubMed:28242692, PubMed:32494070). Promotes ESCRT-mediated NE closure by recruiting CHMP7 and downstream ESCRT-III proteins IST1/CHMP8 and CHMP2A to the reforming NE during anaphase (PubMed:28242692). During nuclear reassembly, condenses into a liquid-like coating around microtubule spindles and coassembles with CHMP7 to form a macromolecular O-ring seal at the confluence between membranes, chromatin, and the spindle to facilitate early nuclear sealing (PubMed:32494070). Plays a role in the organization of heterochromatin associated with the NE and in the maintenance of NE organization under mechanical stress (By similarity). Required for embryonic development and involved in regulation of several signaling pathways such as MAPK and AKT (By similarity). Required for myoblast differentiation involving regulation of ERK signaling (By similarity). Essential for cardiac homeostasis and proper heart function (By similarity). {ECO:0000250|UniProtKB:Q6DVA0, ECO:0000269|PubMed:16339967, ECO:0000269|PubMed:17097643, ECO:0000269|PubMed:28242692, ECO:0000269|PubMed:32494070}. |
Q8TBB5 | KLHDC4 | S424 | ochoa | Kelch domain-containing protein 4 | None |
Q8TD16 | BICD2 | S574 | ochoa | Protein bicaudal D homolog 2 (Bic-D 2) | Acts as an adapter protein linking the dynein motor complex to various cargos and converts dynein from a non-processive to a highly processive motor in the presence of dynactin. Facilitates and stabilizes the interaction between dynein and dynactin and activates dynein processivity (the ability to move along a microtubule for a long distance without falling off the track) (PubMed:25814576). Facilitates the binding of RAB6A to the Golgi by stabilizing its GTP-bound form. Regulates coat complex coatomer protein I (COPI)-independent Golgi-endoplasmic reticulum transport via its interaction with RAB6A and recruitment of the dynein-dynactin motor complex (PubMed:25962623). Contributes to nuclear and centrosomal positioning prior to mitotic entry through regulation of both dynein and kinesin-1. During G2 phase of the cell cycle, associates with RANBP2 at the nuclear pores and recruits dynein and dynactin to the nuclear envelope to ensure proper positioning of the nucleus relative to centrosomes prior to the onset of mitosis (By similarity). {ECO:0000250|UniProtKB:Q921C5, ECO:0000269|PubMed:25814576, ECO:0000269|PubMed:25962623}. |
Q8TDY2 | RB1CC1 | S653 | ochoa | RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa) (FIP200) | Involved in autophagy (PubMed:21775823). Regulates early events but also late events of autophagosome formation through direct interaction with Atg16L1 (PubMed:23392225). Required for the formation of the autophagosome-like double-membrane structure that surrounds the Salmonella-containing vacuole (SCV) during S.typhimurium infection and subsequent xenophagy (By similarity). Involved in repair of DNA damage caused by ionizing radiation, which subsequently improves cell survival by decreasing apoptosis (By similarity). Inhibits PTK2/FAK1 and PTK2B/PYK2 kinase activity, affecting their downstream signaling pathways (PubMed:10769033, PubMed:12221124). Plays a role as a modulator of TGF-beta-signaling by restricting substrate specificity of RNF111 (By similarity). Functions as a DNA-binding transcription factor (PubMed:12095676). Is a potent regulator of the RB1 pathway through induction of RB1 expression (PubMed:14533007). Plays a crucial role in muscular differentiation (PubMed:12163359). Plays an indispensable role in fetal hematopoiesis and in the regulation of neuronal homeostasis (By similarity). {ECO:0000250|UniProtKB:Q9ESK9, ECO:0000269|PubMed:10769033, ECO:0000269|PubMed:12095676, ECO:0000269|PubMed:12163359, ECO:0000269|PubMed:12221124, ECO:0000269|PubMed:14533007, ECO:0000269|PubMed:21775823, ECO:0000269|PubMed:23392225}. |
Q8TED9 | AFAP1L1 | S104 | ochoa | Actin filament-associated protein 1-like 1 (AFAP1-like protein 1) | May be involved in podosome and invadosome formation. {ECO:0000269|PubMed:21333378}. |
Q8TEK3 | DOT1L | S1065 | ochoa | Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) | Histone methyltransferase. Methylates 'Lys-79' of histone H3. Nucleosomes are preferred as substrate compared to free histones (PubMed:12123582). Binds to DNA (PubMed:12628190). {ECO:0000269|PubMed:12123582, ECO:0000269|PubMed:12628190}. |
Q8WUF5 | PPP1R13L | S358 | ochoa | RelA-associated inhibitor (Inhibitor of ASPP protein) (Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein) | Regulator that plays a central role in regulation of apoptosis and transcription via its interaction with NF-kappa-B and p53/TP53 proteins. Blocks transcription of HIV-1 virus by inhibiting the action of both NF-kappa-B and SP1. Also inhibits p53/TP53 function, possibly by preventing the association between p53/TP53 and ASPP1 or ASPP2, and therefore suppressing the subsequent activation of apoptosis (PubMed:12524540). Is involved in NF-kappa-B dependent negative regulation of inflammatory response (PubMed:28069640). {ECO:0000269|PubMed:10336463, ECO:0000269|PubMed:12134007, ECO:0000269|PubMed:12524540, ECO:0000269|PubMed:15489900, ECO:0000269|PubMed:28069640}. |
Q8WVB6 | CHTF18 | S871 | ochoa | Chromosome transmission fidelity protein 18 homolog (hCTF18) (CHL12) | Chromosome cohesion factor involved in sister chromatid cohesion and fidelity of chromosome transmission. Component of one of the cell nuclear antigen loader complexes, CTF18-replication factor C (CTF18-RFC), which consists of CTF18, CTF8, DCC1, RFC2, RFC3, RFC4 and RFC5. The CTF18-RFC complex binds to single-stranded and primed DNAs and has weak ATPase activity that is stimulated by the presence of primed DNA, replication protein A (RPA) and by proliferating cell nuclear antigen (PCNA). The CTF18-RFC complex catalyzes the ATP-dependent loading of PCNA onto primed and gapped DNA. Interacts with and stimulates DNA polymerase POLH. During DNA repair synthesis, involved in loading DNA polymerase POLE at the sites of local damage (PubMed:20227374). {ECO:0000269|PubMed:12766176, ECO:0000269|PubMed:12930902, ECO:0000269|PubMed:17545166, ECO:0000269|PubMed:20227374}. |
Q8WWM7 | ATXN2L | S32 | ochoa | Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein) | Involved in the regulation of stress granule and P-body formation. {ECO:0000269|PubMed:23209657}. |
Q8WXD9 | CASKIN1 | S1242 | ochoa | Caskin-1 (CASK-interacting protein 1) | May link the scaffolding protein CASK to downstream intracellular effectors. {ECO:0000250}. |
Q8WYP5 | AHCTF1 | S1087 | ochoa | Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1) | Required for the assembly of a functional nuclear pore complex (NPC) on the surface of chromosomes as nuclei form at the end of mitosis. May initiate NPC assembly by binding to chromatin and recruiting the Nup107-160 subcomplex of the NPC. Also required for the localization of the Nup107-160 subcomplex of the NPC to the kinetochore during mitosis and for the completion of cytokinesis. {ECO:0000269|PubMed:17098863, ECO:0000269|PubMed:17235358}. |
Q92619 | ARHGAP45 | S99 | ochoa | Rho GTPase-activating protein 45 [Cleaved into: Minor histocompatibility antigen HA-1 (mHag HA-1)] | Contains a GTPase activator for the Rho-type GTPases (RhoGAP) domain that would be able to negatively regulate the actin cytoskeleton as well as cell spreading. However, also contains N-terminally a BAR-domin which is able to play an autoinhibitory effect on this RhoGAP activity. {ECO:0000269|PubMed:24086303}.; FUNCTION: Precursor of the histocompatibility antigen HA-1. More generally, minor histocompatibility antigens (mHags) refer to immunogenic peptide which, when complexed with MHC, can generate an immune response after recognition by specific T-cells. The peptides are derived from polymorphic intracellular proteins, which are cleaved by normal pathways of antigen processing. The binding of these peptides to MHC class I or class II molecules and its expression on the cell surface can stimulate T-cell responses and thereby trigger graft rejection or graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation from HLA-identical sibling donor. GVHD is a frequent complication after bone marrow transplantation (BMT), due to mismatch of minor histocompatibility antigen in HLA-matched sibling marrow transplants. Specifically, mismatching for mHag HA-1 which is recognized as immunodominant, is shown to be associated with the development of severe GVHD after HLA-identical BMT. HA-1 is presented to the cell surface by MHC class I HLA-A*0201, but also by other HLA-A alleles. This complex specifically elicits donor-cytotoxic T-lymphocyte (CTL) reactivity against hematologic malignancies after treatment by HLA-identical allogenic BMT. It induces cell recognition and lysis by CTL. {ECO:0000269|PubMed:12601144, ECO:0000269|PubMed:8260714, ECO:0000269|PubMed:8532022, ECO:0000269|PubMed:9798702}. |
Q92729 | PTPRU | S853 | ochoa | Receptor-type tyrosine-protein phosphatase U (R-PTP-U) (EC 3.1.3.48) (Pancreatic carcinoma phosphatase 2) (PCP-2) (Protein-tyrosine phosphatase J) (PTP-J) (hPTP-J) (Protein-tyrosine phosphatase pi) (PTP pi) (Protein-tyrosine phosphatase receptor omicron) (PTP-RO) (Receptor-type protein-tyrosine phosphatase psi) (R-PTP-psi) | Tyrosine-protein phosphatase which dephosphorylates CTNNB1. Regulates CTNNB1 function both in cell adhesion and signaling. May function in cell proliferation and migration and play a role in the maintenance of epithelial integrity. May play a role in megakaryocytopoiesis. {ECO:0000269|PubMed:10397721, ECO:0000269|PubMed:12501215, ECO:0000269|PubMed:16574648}. |
Q92766 | RREB1 | S42 | ochoa | Ras-responsive element-binding protein 1 (RREB-1) (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1) (Zep-1) | Transcription factor that binds specifically to the RAS-responsive elements (RRE) of gene promoters (PubMed:10390538, PubMed:15067362, PubMed:17550981, PubMed:8816445, PubMed:9305772). Represses the angiotensinogen gene (PubMed:15067362). Negatively regulates the transcriptional activity of AR (PubMed:17550981). Potentiates the transcriptional activity of NEUROD1 (PubMed:12482979). Promotes brown adipocyte differentiation (By similarity). May be involved in Ras/Raf-mediated cell differentiation by enhancing calcitonin expression (PubMed:8816445). {ECO:0000250|UniProtKB:Q3UH06, ECO:0000269|PubMed:10390538, ECO:0000269|PubMed:12482979, ECO:0000269|PubMed:15067362, ECO:0000269|PubMed:17550981, ECO:0000269|PubMed:8816445, ECO:0000269|PubMed:9305772}. |
Q96C12 | ARMC5 | S102 | ochoa | Armadillo repeat-containing protein 5 | Substrate-recognition component of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex that terminates RNA polymerase II (Pol II) transcription in the promoter-proximal region of genes (PubMed:39504960, PubMed:39667934). The BCR(ARMC5) complex provides a quality checkpoint during transcription elongation by driving premature transcription termination of transcripts that are unfavorably configured for transcriptional elongation: the BCR(ARMC5) complex acts by mediating ubiquitination of Pol II subunit POLR2A phosphorylated at 'Ser-5' of the C-terminal domain (CTD), leading to POLR2A degradation (PubMed:35687106, PubMed:38225631, PubMed:39504960, PubMed:39667934). The BCR(ARMC5) complex acts in parallel of the integrator complex and is specific for RNA Pol II originating from the promoter-proximal zone: it does not ubiquitinate elongation-stalled RNA Pol II (PubMed:39667934). The BCR(ARMC5) complex also acts as a regulator of fatty acid desaturation by mediating ubiquitination and degradation of SCAP-free SREBF1 and SREBF2 (PubMed:35862218). Involved in fetal development, T-cell function and adrenal gland growth homeostasis (PubMed:24283224, PubMed:28676429). Plays a role in steroidogenesis, modulates steroidogenic enzymes expression and cortisol production (PubMed:24283224, PubMed:28676429). {ECO:0000269|PubMed:24283224, ECO:0000269|PubMed:28676429, ECO:0000269|PubMed:35687106, ECO:0000269|PubMed:35862218, ECO:0000269|PubMed:38225631, ECO:0000269|PubMed:39504960, ECO:0000269|PubMed:39667934}. |
Q96GM8 | TOE1 | S428 | ochoa | Target of EGR1 protein 1 | Inhibits cell growth rate and cell cycle. Induces CDKN1A expression as well as TGF-beta expression. Mediates the inhibitory growth effect of EGR1. Involved in the maturation of snRNAs and snRNA 3'-tail processing (PubMed:28092684). {ECO:0000269|PubMed:12562764, ECO:0000269|PubMed:28092684}. |
Q96I34 | PPP1R16A | S478 | ochoa | Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase-targeting subunit 3) | Inhibits protein phosphatase 1 activity toward phosphorylase, myosin light chain and myosin substrates. {ECO:0000250}. |
Q96NA2 | RILP | S361 | ochoa | Rab-interacting lysosomal protein | Rab effector playing a role in late endocytic transport to degradative compartments (PubMed:11179213, PubMed:11696325, PubMed:12944476, PubMed:14668488, PubMed:27113757). Involved in the regulation of lysosomal morphology and distribution (PubMed:14668488, PubMed:27113757). Induces recruitment of dynein-dynactin motor complexes to Rab7A-containing late endosome and lysosome compartments (PubMed:11179213, PubMed:11696325). Promotes centripetal migration of phagosomes and the fusion of phagosomes with the late endosomes and lysosomes (PubMed:12944476). {ECO:0000269|PubMed:11179213, ECO:0000269|PubMed:11696325, ECO:0000269|PubMed:12944476, ECO:0000269|PubMed:14668488, ECO:0000269|PubMed:27113757}. |
Q96NU1 | SAMD11 | S646 | ochoa | Sterile alpha motif domain-containing protein 11 (SAM domain-containing protein 11) | Component of a Polycomb group (PcG) multiprotein PRC1-like complex, essential for establishing rod photoreceptor cell identity and function by silencing nonrod gene expression in developing rod photoreceptor cells. {ECO:0000250|UniProtKB:Q1RNF8}. |
Q96NY9 | MUS81 | S101 | ochoa | Structure-specific endonuclease subunit MUS81 (EC 3.1.22.-) (Crossover junction endonuclease MUS81) (MUS81 endonuclease homolog) | Catalytic subunit of two functionally distinct, structure-specific, heterodimeric DNA endonucleases MUS81-EME1 and MUS81-EME2 that are involved in the maintenance of genome stability (PubMed:11741546, PubMed:12374758, PubMed:12686547, PubMed:12721304, PubMed:24371268, PubMed:24733841, PubMed:24813886, PubMed:35290797, PubMed:39015284). Both endonucleases have essentially the same substrate specificity though MUS81-EME2 is more active than its MUS81-EME1 counterpart. Both cleave 3'-flaps and nicked Holliday junctions, and exhibit limited endonuclease activity with 5' flaps and nicked double-stranded DNAs (PubMed:24371268, PubMed:24733841, PubMed:35290797). MUS81-EME2 which is active during the replication of DNA is more specifically involved in replication fork processing (PubMed:24813886). Replication forks frequently encounter obstacles to their passage, including DNA base lesions, DNA interstrand cross-links, difficult-to-replicate sequences, transcription bubbles, or tightly bound proteins. One mechanism for the restart of a stalled replication fork involves nucleolytic cleavage mediated by the MUS81-EME2 endonuclease. By acting upon the stalled fork, MUS81-EME2 generates a DNA double-strand break (DSB) that can be repaired by homologous recombination, leading to the restoration of an active fork (PubMed:24813886). MUS81-EME2 could also function in telomere maintenance (PubMed:24813886). MUS81-EME1, on the other hand, is active later in the cell cycle and functions in the resolution of mitotic recombination intermediates including the Holliday junctions, the four-way DNA intermediates that form during homologous recombination (PubMed:11741546, PubMed:12374758, PubMed:14617801, PubMed:15805243, PubMed:24813886). {ECO:0000269|PubMed:11741546, ECO:0000269|PubMed:12374758, ECO:0000269|PubMed:12686547, ECO:0000269|PubMed:12721304, ECO:0000269|PubMed:14617801, ECO:0000269|PubMed:15805243, ECO:0000269|PubMed:24371268, ECO:0000269|PubMed:24733841, ECO:0000269|PubMed:24813886, ECO:0000269|PubMed:35290797, ECO:0000269|PubMed:39015284}. |
Q96T58 | SPEN | S2120 | ochoa | Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog) | May serve as a nuclear matrix platform that organizes and integrates transcriptional responses. In osteoblasts, supports transcription activation: synergizes with RUNX2 to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element (OCFRE) (By similarity). Has also been shown to be an essential corepressor protein, which probably regulates different key pathways such as the Notch pathway. Negative regulator of the Notch pathway via its interaction with RBPSUH, which prevents the association between NOTCH1 and RBPSUH, and therefore suppresses the transactivation activity of Notch signaling. Blocks the differentiation of precursor B-cells into marginal zone B-cells. Probably represses transcription via the recruitment of large complexes containing histone deacetylase proteins. May bind both to DNA and RNA. {ECO:0000250|UniProtKB:Q62504, ECO:0000269|PubMed:11331609, ECO:0000269|PubMed:12374742}. |
Q96T58 | SPEN | S2126 | ochoa | Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog) | May serve as a nuclear matrix platform that organizes and integrates transcriptional responses. In osteoblasts, supports transcription activation: synergizes with RUNX2 to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element (OCFRE) (By similarity). Has also been shown to be an essential corepressor protein, which probably regulates different key pathways such as the Notch pathway. Negative regulator of the Notch pathway via its interaction with RBPSUH, which prevents the association between NOTCH1 and RBPSUH, and therefore suppresses the transactivation activity of Notch signaling. Blocks the differentiation of precursor B-cells into marginal zone B-cells. Probably represses transcription via the recruitment of large complexes containing histone deacetylase proteins. May bind both to DNA and RNA. {ECO:0000250|UniProtKB:Q62504, ECO:0000269|PubMed:11331609, ECO:0000269|PubMed:12374742}. |
Q99081 | TCF12 | S354 | ochoa | Transcription factor 12 (TCF-12) (Class B basic helix-loop-helix protein 20) (bHLHb20) (DNA-binding protein HTF4) (E-box-binding protein) (Transcription factor HTF-4) | Transcriptional regulator. Involved in the initiation of neuronal differentiation. Activates transcription by binding to the E box (5'-CANNTG-3') (By similarity). May be involved in the functional network that regulates the development of the GnRH axis (PubMed:32620954). {ECO:0000250|UniProtKB:Q61286, ECO:0000269|PubMed:32620954}. |
Q99575 | POP1 | S730 | ochoa | Ribonucleases P/MRP protein subunit POP1 (hPOP1) | Component of ribonuclease P, a ribonucleoprotein complex that generates mature tRNA molecules by cleaving their 5'-ends (PubMed:30454648, PubMed:8918471). Also a component of the MRP ribonuclease complex, which cleaves pre-rRNA sequences (PubMed:28115465). {ECO:0000269|PubMed:28115465, ECO:0000269|PubMed:30454648, ECO:0000269|PubMed:8918471}. |
Q9BRD0 | BUD13 | S364 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9BRQ0 | PYGO2 | S97 | ochoa | Pygopus homolog 2 | Involved in signal transduction through the Wnt pathway. |
Q9BWT3 | PAPOLG | S29 | ochoa | Poly(A) polymerase gamma (PAP-gamma) (EC 2.7.7.19) (Neo-poly(A) polymerase) (Neo-PAP) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme) (SRP RNA-adenylating enzyme) | Responsible for the post-transcriptional adenylation of the 3'-terminal of mRNA precursors and several small RNAs including signal recognition particle (SRP) RNA, nuclear 7SK RNA, U2 small nuclear RNA, and ribosomal 5S RNA. {ECO:0000269|PubMed:11287430, ECO:0000269|PubMed:11463842}. |
Q9BYB0 | SHANK3 | S366 | ochoa | SH3 and multiple ankyrin repeat domains protein 3 (Shank3) (Proline-rich synapse-associated protein 2) (ProSAP2) | Major scaffold postsynaptic density protein which interacts with multiple proteins and complexes to orchestrate the dendritic spine and synapse formation, maturation and maintenance. Interconnects receptors of the postsynaptic membrane including NMDA-type and metabotropic glutamate receptors via complexes with GKAP/PSD-95 and HOMER, respectively, and the actin-based cytoskeleton. Plays a role in the structural and functional organization of the dendritic spine and synaptic junction through the interaction with Arp2/3 and WAVE1 complex as well as the promotion of the F-actin clusters. By way of this control of actin dynamics, participates in the regulation of developing neurons growth cone motility and the NMDA receptor-signaling. Also modulates GRIA1 exocytosis and GRM5/MGLUR5 expression and signaling to control the AMPA and metabotropic glutamate receptor-mediated synaptic transmission and plasticity. May be required at an early stage of synapse formation and be inhibited by IGF1 to promote synapse maturation. {ECO:0000269|PubMed:24132240}. |
Q9H1H9 | KIF13A | S1460 | ochoa | Kinesin-like protein KIF13A (Kinesin-like protein RBKIN) | Plus end-directed microtubule-dependent motor protein involved in intracellular transport and regulating various processes such as mannose-6-phosphate receptor (M6PR) transport to the plasma membrane, endosomal sorting during melanosome biogenesis and cytokinesis. Mediates the transport of M6PR-containing vesicles from trans-Golgi network to the plasma membrane via direct interaction with the AP-1 complex. During melanosome maturation, required for delivering melanogenic enzymes from recycling endosomes to nascent melanosomes by creating peripheral recycling endosomal subdomains in melanocytes. Also required for the abscission step in cytokinesis: mediates translocation of ZFYVE26, and possibly TTC19, to the midbody during cytokinesis. {ECO:0000269|PubMed:19841138, ECO:0000269|PubMed:20208530}. |
Q9H1R3 | MYLK2 | S149 | ochoa | Myosin light chain kinase 2, skeletal/cardiac muscle (MLCK2) (EC 2.7.11.18) | Implicated in the level of global muscle contraction and cardiac function. Phosphorylates a specific serine in the N-terminus of a myosin light chain. {ECO:0000269|PubMed:11733062}. |
Q9H211 | CDT1 | S79 | ochoa | DNA replication factor Cdt1 (Double parked homolog) (DUP) | Required for both DNA replication and mitosis (PubMed:11125146, PubMed:14993212, PubMed:21856198, PubMed:22581055, PubMed:26842564). DNA replication licensing factor, required for pre-replication complex assembly. Cooperates with CDC6 and the origin recognition complex (ORC) during G1 phase of the cell cycle to promote the loading of the mini-chromosome maintenance (MCM) complex onto DNA to generate pre-replication complexes (pre-RC) (PubMed:14672932). Required also for mitosis by promoting stable kinetochore-microtubule attachments (PubMed:22581055). Potential oncogene (By similarity). {ECO:0000250|UniProtKB:Q8R4E9, ECO:0000269|PubMed:11125146, ECO:0000269|PubMed:14672932, ECO:0000269|PubMed:14993212, ECO:0000269|PubMed:21856198, ECO:0000269|PubMed:22581055, ECO:0000269|PubMed:26842564}. |
Q9H2D6 | TRIOBP | S1955 | ochoa | TRIO and F-actin-binding protein (Protein Tara) (TRF1-associated protein of 68 kDa) (Trio-associated repeat on actin) | [Isoform 1]: Regulates actin cytoskeletal organization, cell spreading and cell contraction by directly binding and stabilizing filamentous F-actin and prevents its depolymerization (PubMed:18194665, PubMed:28438837). May also serve as a linker protein to recruit proteins required for F-actin formation and turnover (PubMed:18194665). Essential for correct mitotic progression (PubMed:22820163, PubMed:24692559). {ECO:0000269|PubMed:18194665, ECO:0000269|PubMed:22820163, ECO:0000269|PubMed:24692559, ECO:0000269|PubMed:28438837}.; FUNCTION: [Isoform 5]: Plays a pivotal role in the formation of stereocilia rootlets. {ECO:0000250|UniProtKB:Q99KW3}.; FUNCTION: [Isoform 4]: Plays a pivotal role in the formation of stereocilia rootlets. {ECO:0000250|UniProtKB:Q99KW3}. |
Q9H2I8 | LRMDA | S153 | ochoa | Leucine-rich melanocyte differentiation-associated protein | Required for melanocyte differentiation. {ECO:0000269|PubMed:23395477}. |
Q9H4Z2 | ZNF335 | S992 | ochoa | Zinc finger protein 335 (NRC-interacting factor 1) (NIF-1) | Component or associated component of some histone methyltransferase complexes may regulate transcription through recruitment of those complexes on gene promoters (PubMed:19131338, PubMed:23178126). Enhances ligand-dependent transcriptional activation by nuclear hormone receptors (PubMed:12215545, PubMed:18180299, PubMed:19131338). Plays an important role in neural progenitor cell proliferation and self-renewal through the regulation of specific genes involved brain development, including REST (PubMed:23178126). Also controls the expression of genes involved in somatic development and regulates, for instance, lymphoblast proliferation (PubMed:23178126). {ECO:0000269|PubMed:12215545, ECO:0000269|PubMed:18180299, ECO:0000269|PubMed:19131338, ECO:0000269|PubMed:23178126}. |
Q9H6K5 | PRR36 | S116 | ochoa | Proline-rich protein 36 | None |
Q9H6R4 | NOL6 | S289 | ochoa | Nucleolar protein 6 (Nucleolar RNA-associated protein) (Nrap) | Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome. {ECO:0000269|PubMed:11895476, ECO:0000269|PubMed:34516797}. |
Q9H8M5 | CNNM2 | S749 | ochoa | Metal transporter CNNM2 (Ancient conserved domain-containing protein 2) (Cyclin-M2) | Divalent metal cation transporter. Mediates transport of divalent metal cations in an order of Mg(2+) > Co(2+) > Mn(2+) > Sr(2+) > Ba(2+) > Cu(2+) > Fe(2+) (By similarity). {ECO:0000250|UniProtKB:Q3TWN3}. |
Q9H9D4 | ZNF408 | S338 | ochoa | Zinc finger protein 408 (PR domain zinc finger protein 17) | May be involved in transcriptional regulation. |
Q9HAU0 | PLEKHA5 | S1098 | ochoa | Pleckstrin homology domain-containing family A member 5 (PH domain-containing family A member 5) (Phosphoinositol 3-phosphate-binding protein 2) (PEPP-2) | None |
Q9HBE1 | PATZ1 | S249 | ochoa | POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein) | Transcriptional regulator that plays a role in many biological processes such as embryogenesis, senescence, T-cell development or neurogenesis (PubMed:10713105, PubMed:25755280, PubMed:31875552). Interacts with the TP53 protein to control genes that are important in proliferation and in the DNA-damage response. Mechanistically, the interaction inhibits the DNA binding and transcriptional activity of TP53/p53 (PubMed:25755280). Part of the transcriptional network modulating regulatory T-cell development and controls the generation of the regulatory T-cell pool under homeostatic conditions (PubMed:31875552). {ECO:0000269|PubMed:10713105, ECO:0000269|PubMed:25755280, ECO:0000269|PubMed:31875552}.; FUNCTION: (Microbial infection) Plays a positive role in viral cDNA synthesis. {ECO:0000269|PubMed:31060775}. |
Q9HC35 | EML4 | S144 | ochoa|psp | Echinoderm microtubule-associated protein-like 4 (EMAP-4) (Restrictedly overexpressed proliferation-associated protein) (Ropp 120) | Essential for the formation and stability of microtubules (MTs) (PubMed:16890222, PubMed:31409757). Required for the organization of the mitotic spindle and for the proper attachment of kinetochores to MTs (PubMed:25789526). Promotes the recruitment of NUDC to the mitotic spindle for mitotic progression (PubMed:25789526). {ECO:0000269|PubMed:16890222, ECO:0000269|PubMed:25789526, ECO:0000269|PubMed:31409757}. |
Q9HCM7 | FBRSL1 | S141 | ochoa | Fibrosin-1-like protein (AUTS2-like protein) (HBV X-transactivated gene 9 protein) (HBV XAg-transactivated protein 9) | None |
Q9NQS7 | INCENP | S269 | ochoa | Inner centromere protein | Component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Acts as a scaffold regulating CPC localization and activity. The C-terminus associates with AURKB or AURKC, the N-terminus associated with BIRC5/survivin and CDCA8/borealin tethers the CPC to the inner centromere, and the microtubule binding activity within the central SAH domain directs AURKB/C toward substrates near microtubules (PubMed:12925766, PubMed:15316025, PubMed:27332895). The flexibility of the SAH domain is proposed to allow AURKB/C to follow substrates on dynamic microtubules while ensuring CPC docking to static chromatin (By similarity). Activates AURKB and AURKC (PubMed:27332895). Required for localization of CBX5 to mitotic centromeres (PubMed:21346195). Controls the kinetochore localization of BUB1 (PubMed:16760428). {ECO:0000250|UniProtKB:P53352, ECO:0000269|PubMed:12925766, ECO:0000269|PubMed:15316025, ECO:0000269|PubMed:16760428, ECO:0000269|PubMed:21346195, ECO:0000269|PubMed:27332895}. |
Q9NQS7 | INCENP | S312 | ochoa | Inner centromere protein | Component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Acts as a scaffold regulating CPC localization and activity. The C-terminus associates with AURKB or AURKC, the N-terminus associated with BIRC5/survivin and CDCA8/borealin tethers the CPC to the inner centromere, and the microtubule binding activity within the central SAH domain directs AURKB/C toward substrates near microtubules (PubMed:12925766, PubMed:15316025, PubMed:27332895). The flexibility of the SAH domain is proposed to allow AURKB/C to follow substrates on dynamic microtubules while ensuring CPC docking to static chromatin (By similarity). Activates AURKB and AURKC (PubMed:27332895). Required for localization of CBX5 to mitotic centromeres (PubMed:21346195). Controls the kinetochore localization of BUB1 (PubMed:16760428). {ECO:0000250|UniProtKB:P53352, ECO:0000269|PubMed:12925766, ECO:0000269|PubMed:15316025, ECO:0000269|PubMed:16760428, ECO:0000269|PubMed:21346195, ECO:0000269|PubMed:27332895}. |
Q9NUE0 | ZDHHC18 | S30 | ochoa | Palmitoyltransferase ZDHHC18 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 18) (DHHC-18) (Zinc finger DHHC domain-containing protein 18) | Palmitoyltransferase that catalyzes the addition of palmitate onto various protein substrates, such as CGAS, HRAS and LCK (PubMed:23034182, PubMed:27481942, PubMed:35438208). Acts as a negative regulator of the cGAS-STING pathway be mediating palmitoylation and inactivation of CGAS (PubMed:35438208). May also have a palmitoyltransferase activity toward the beta-2 adrenergic receptor/ADRB2 and therefore regulate G protein-coupled receptor signaling (PubMed:27481942). {ECO:0000269|PubMed:23034182, ECO:0000269|PubMed:27481942, ECO:0000269|PubMed:35438208}. |
Q9NWS9 | ZNF446 | S188 | ochoa | Zinc finger protein 446 (Zinc finger protein with KRAB and SCAN domains 20) | May be involved in transcriptional regulation. |
Q9NYL2 | MAP3K20 | S733 | ochoa | Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase 7) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK) | Stress-activated component of a protein kinase signal transduction cascade that promotes programmed cell death in response to various stress, such as ribosomal stress, osmotic shock and ionizing radiation (PubMed:10924358, PubMed:11836244, PubMed:12220515, PubMed:14521931, PubMed:15350844, PubMed:15737997, PubMed:18331592, PubMed:20559024, PubMed:26999302, PubMed:32289254, PubMed:32610081, PubMed:35857590). Acts by catalyzing phosphorylation of MAP kinase kinases, leading to activation of the JNK (MAPK8/JNK1, MAPK9/JNK2 and/or MAPK10/JNK3) and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways (PubMed:11042189, PubMed:11836244, PubMed:12220515, PubMed:14521931, PubMed:15172994, PubMed:15737997, PubMed:32289254, PubMed:32610081, PubMed:35857590). Activates JNK through phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7, and MAP kinase p38 gamma (MAPK12) via phosphorylation of MAP2K3/MKK3 and MAP2K6/MKK6 (PubMed:11836244, PubMed:12220515). Involved in stress associated with adrenergic stimulation: contributes to cardiac decompensation during periods of acute cardiac stress (PubMed:15350844, PubMed:21224381, PubMed:27859413). May be involved in regulation of S and G2 cell cycle checkpoint by mediating phosphorylation of CHEK2 (PubMed:15342622). {ECO:0000269|PubMed:10924358, ECO:0000269|PubMed:11042189, ECO:0000269|PubMed:11836244, ECO:0000269|PubMed:12220515, ECO:0000269|PubMed:14521931, ECO:0000269|PubMed:15172994, ECO:0000269|PubMed:15342622, ECO:0000269|PubMed:15350844, ECO:0000269|PubMed:15737997, ECO:0000269|PubMed:18331592, ECO:0000269|PubMed:20559024, ECO:0000269|PubMed:21224381, ECO:0000269|PubMed:26999302, ECO:0000269|PubMed:27859413, ECO:0000269|PubMed:32289254, ECO:0000269|PubMed:32610081, ECO:0000269|PubMed:35857590}.; FUNCTION: [Isoform ZAKalpha]: Key component of the stress-activated protein kinase signaling cascade in response to ribotoxic stress or UV-B irradiation (PubMed:32289254, PubMed:32610081, PubMed:35857590). Acts as the proximal sensor of ribosome collisions during the ribotoxic stress response (RSR): directly binds to the ribosome by inserting its flexible C-terminus into the ribosomal intersubunit space, thereby acting as a sentinel for colliding ribosomes (PubMed:32289254, PubMed:32610081). Upon ribosome collisions, activates either the stress-activated protein kinase signal transduction cascade or the integrated stress response (ISR), leading to programmed cell death or cell survival, respectively (PubMed:32610081). Dangerous levels of ribosome collisions trigger the autophosphorylation and activation of MAP3K20, which dissociates from colliding ribosomes and phosphorylates MAP kinase kinases, leading to activation of the JNK and MAP kinase p38 pathways that promote programmed cell death (PubMed:32289254, PubMed:32610081). Less dangerous levels of ribosome collisions trigger the integrated stress response (ISR): MAP3K20 activates EIF2AK4/GCN2 independently of its protein-kinase activity, promoting EIF2AK4/GCN2-mediated phosphorylation of EIF2S1/eIF-2-alpha (PubMed:32610081). Also part of the stress-activated protein kinase signaling cascade triggering the NLRP1 inflammasome in response to UV-B irradiation: ribosome collisions activate MAP3K20, which directly phosphorylates NLRP1, leading to activation of the NLRP1 inflammasome and subsequent pyroptosis (PubMed:35857590). NLRP1 is also phosphorylated by MAP kinase p38 downstream of MAP3K20 (PubMed:35857590). Also acts as a histone kinase by phosphorylating histone H3 at 'Ser-28' (H3S28ph) (PubMed:15684425). {ECO:0000269|PubMed:15684425, ECO:0000269|PubMed:32289254, ECO:0000269|PubMed:32610081, ECO:0000269|PubMed:35857590}.; FUNCTION: [Isoform ZAKbeta]: Isoform that lacks the C-terminal region that mediates ribosome-binding: does not act as a sensor of ribosome collisions in response to ribotoxic stress (PubMed:32289254, PubMed:32610081, PubMed:35857590). May act as an antagonist of isoform ZAKalpha: interacts with isoform ZAKalpha, leading to decrease the expression of isoform ZAKalpha (PubMed:27859413). {ECO:0000269|PubMed:27859413, ECO:0000269|PubMed:32289254, ECO:0000269|PubMed:32610081, ECO:0000269|PubMed:35857590}. |
Q9NZM4 | BICRA | S1534 | ochoa | BRD4-interacting chromatin-remodeling complex-associated protein (Glioma tumor suppressor candidate region gene 1 protein) | Component of SWI/SNF chromatin remodeling subcomplex GBAF that carries out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner (PubMed:29374058). May play a role in BRD4-mediated gene transcription (PubMed:21555454). {ECO:0000269|PubMed:21555454, ECO:0000269|PubMed:29374058}. |
Q9NZT2 | OGFR | S525 | ochoa | Opioid growth factor receptor (OGFr) (Protein 7-60) (Zeta-type opioid receptor) | Receptor for opioid growth factor (OGF), also known as Met-enkephalin. Seems to be involved in growth regulation. |
Q9NZT2 | OGFR | S585 | ochoa | Opioid growth factor receptor (OGFr) (Protein 7-60) (Zeta-type opioid receptor) | Receptor for opioid growth factor (OGF), also known as Met-enkephalin. Seems to be involved in growth regulation. |
Q9P206 | NHSL3 | S286 | ochoa | NHS-like protein 3 | Able to directly activate the TNF-NFkappaB signaling pathway. {ECO:0000269|PubMed:32854746}. |
Q9P242 | NYAP2 | S413 | ochoa | Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2 | Activates PI3K and concomitantly recruits the WAVE1 complex to the close vicinity of PI3K and regulates neuronal morphogenesis. {ECO:0000250}. |
Q9P270 | SLAIN2 | S462 | ochoa | SLAIN motif-containing protein 2 | Binds to the plus end of microtubules and regulates microtubule dynamics and microtubule organization. Promotes cytoplasmic microtubule nucleation and elongation. Required for normal structure of the microtubule cytoskeleton during interphase. {ECO:0000269|PubMed:21646404}. |
Q9UD71 | PPP1R1B | S52 | ochoa | Protein phosphatase 1 regulatory subunit 1B (DARPP-32) (Dopamine- and cAMP-regulated neuronal phosphoprotein) | Inhibitor of protein-phosphatase 1. |
Q9UGP4 | LIMD1 | S353 | ochoa | LIM domain-containing protein 1 | Adapter or scaffold protein which participates in the assembly of numerous protein complexes and is involved in several cellular processes such as cell fate determination, cytoskeletal organization, repression of gene transcription, cell-cell adhesion, cell differentiation, proliferation and migration. Positively regulates microRNA (miRNA)-mediated gene silencing and is essential for P-body formation and integrity. Acts as a hypoxic regulator by bridging an association between the prolyl hydroxylases and VHL enabling efficient degradation of HIF1A. Acts as a transcriptional corepressor for SNAI1- and SNAI2/SLUG-dependent repression of E-cadherin transcription. Negatively regulates the Hippo signaling pathway and antagonizes phosphorylation of YAP1. Inhibits E2F-mediated transcription, and suppresses the expression of the majority of genes with E2F1-responsive elements. Regulates osteoblast development, function, differentiation and stress osteoclastogenesis. Enhances the ability of TRAF6 to activate adapter protein complex 1 (AP-1) and negatively regulates the canonical Wnt receptor signaling pathway in osteoblasts. May act as a tumor suppressor by inhibiting cell proliferation. {ECO:0000269|PubMed:15542589, ECO:0000269|PubMed:20303269, ECO:0000269|PubMed:20616046, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:22286099}. |
Q9UGY1 | NOL12 | S140 | ochoa | Nucleolar protein 12 | Multifunctional RNA binding protein that plays a role in RNA metabolism and DNA maintenance. Participates in the resolution of DNA stress and the maintenance of genome integrity by localizing to sites of DNA insults (PubMed:29069457). Also plays a role in proper nucleolar organization by limiting nucleolar size and regulating nucleolar number. Mechanistically, regulates the nucleolar levels of fibrillarin and nucleolin, two key players in pre-rRNA processing and ribosome assembly (PubMed:30988155). {ECO:0000269|PubMed:29069457, ECO:0000269|PubMed:30988155}. |
Q9ULD5 | ZNF777 | S502 | ochoa | Zinc finger protein 777 | May be involved in transcriptional repression (PubMed:31856708). Inhibits cell proliferation through CDKN1A/p21 induction by down-regulation of NIBAN1/FAM129A at low cell density (PubMed:25560148). {ECO:0000269|PubMed:25560148, ECO:0000269|PubMed:31856708}. |
Q9ULM3 | YEATS2 | S124 | ochoa | YEATS domain-containing protein 2 | Chromatin reader component of the ATAC complex, a complex with histone acetyltransferase activity on histones H3 and H4 (PubMed:18838386, PubMed:19103755, PubMed:27103431). YEATS2 specifically recognizes and binds histone H3 crotonylated at 'Lys-27' (H3K27cr) (PubMed:27103431). Crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors (PubMed:27103431). {ECO:0000269|PubMed:18838386, ECO:0000269|PubMed:19103755, ECO:0000269|PubMed:27103431}. |
Q9UM47 | NOTCH3 | S2032 | ochoa | Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain] | Functions as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination (PubMed:15350543). Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs (By similarity). {ECO:0000250|UniProtKB:Q9R172, ECO:0000269|PubMed:15350543}. |
Q9UN79 | SOX13 | S83 | ochoa | Transcription factor SOX-13 (Islet cell antigen 12) (SRY (Sex determining region Y)-box 13) (Type 1 diabetes autoantigen ICA12) | Transcription factor that binds to DNA at the consensus sequence 5'-AACAAT-3' (PubMed:10871192). Binds to the proximal promoter region of the myelin protein MPZ gene, and may thereby be involved in the differentiation of oligodendroglia in the developing spinal tube (By similarity). Binds to the gene promoter of MBP and acts as a transcriptional repressor (By similarity). Binds to and modifies the activity of TCF7/TCF1, thereby inhibiting transcription and modulates normal gamma-delta T-cell development and differentiation of IL17A expressing gamma-delta T-cells (By similarity). Regulates expression of BLK in the differentiation of IL17A expressing gamma-delta T-cells (By similarity). Promotes brown adipocyte differentiation (By similarity). Inhibitor of WNT signaling (PubMed:20028982). {ECO:0000250|UniProtKB:Q04891, ECO:0000269|PubMed:10871192, ECO:0000269|PubMed:20028982}. |
Q9UPQ9 | TNRC6B | S1336 | ochoa | Trinucleotide repeat-containing gene 6B protein | Plays a role in RNA-mediated gene silencing by both micro-RNAs (miRNAs) and short interfering RNAs (siRNAs) (PubMed:16289642, PubMed:19167051, PubMed:19304925, PubMed:32354837). Required for miRNA-dependent translational repression and siRNA-dependent endonucleolytic cleavage of complementary mRNAs by argonaute family proteins (PubMed:16289642, PubMed:19167051, PubMed:19304925, PubMed:32354837). As scaffolding protein associates with argonaute proteins bound to partially complementary mRNAs and simultaneously can recruit CCR4-NOT and PAN deadenylase complexes (PubMed:21981923). {ECO:0000269|PubMed:16289642, ECO:0000269|PubMed:19167051, ECO:0000269|PubMed:19304925, ECO:0000269|PubMed:21981923, ECO:0000269|PubMed:32354837}. |
Q9UQ35 | SRRM2 | S2382 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9Y2H5 | PLEKHA6 | S282 | ochoa | Pleckstrin homology domain-containing family A member 6 (PH domain-containing family A member 6) (Phosphoinositol 3-phosphate-binding protein 3) (PEPP-3) | None |
Q9Y4F5 | CEP170B | S518 | ochoa | Centrosomal protein of 170 kDa protein B (Centrosomal protein 170B) (Cep170B) | Plays a role in microtubule organization. {ECO:0000250|UniProtKB:Q5SW79}. |
Q9Y618 | NCOR2 | S2413 | psp | Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor) | Transcriptional corepressor that mediates the transcriptional repression activity of some nuclear receptors by promoting chromatin condensation, thus preventing access of the basal transcription (PubMed:10077563, PubMed:10097068, PubMed:18212045, PubMed:20812024, PubMed:22230954, PubMed:23911289). Acts by recruiting chromatin modifiers, such as histone deacetylases HDAC1, HDAC2 and HDAC3 (PubMed:22230954). Required to activate the histone deacetylase activity of HDAC3 (PubMed:22230954). Involved in the regulation BCL6-dependent of the germinal center (GC) reactions, mainly through the control of the GC B-cells proliferation and survival (PubMed:18212045, PubMed:23911289). Recruited by ZBTB7A to the androgen response elements/ARE on target genes, negatively regulates androgen receptor signaling and androgen-induced cell proliferation (PubMed:20812024). {ECO:0000269|PubMed:10077563, ECO:0000269|PubMed:10097068, ECO:0000269|PubMed:18212045, ECO:0000269|PubMed:20812024, ECO:0000269|PubMed:22230954, ECO:0000269|PubMed:23911289}.; FUNCTION: [Isoform 1]: Isoform 1 and isoform 4 have different affinities for different nuclear receptors. {ECO:0000269|PubMed:15632172}.; FUNCTION: [Isoform 4]: Isoform 1 and isoform 4 have different affinities for different nuclear receptors. {ECO:0000269|PubMed:15632172}. |
Q9Y6J0 | CABIN1 | S2100 | ochoa | Calcineurin-binding protein cabin-1 (Calcineurin inhibitor) (CAIN) | May be required for replication-independent chromatin assembly. May serve as a negative regulator of T-cell receptor (TCR) signaling via inhibition of calcineurin. Inhibition of activated calcineurin is dependent on both PKC and calcium signals. Acts as a negative regulator of p53/TP53 by keeping p53 in an inactive state on chromatin at promoters of a subset of it's target genes. {ECO:0000269|PubMed:14718166, ECO:0000269|PubMed:9655484}. |
V9GYY5 | None | S133 | ochoa | Nucleolar protein 12 | Multifunctional RNA binding protein that plays a role in RNA metabolism and DNA maintenance. Participates in the resolution of DNA stress and the maintenance of genome integrity by localizing to sites of DNA insults. Also plays a role in proper nucleolar organization by limiting nucleolar size and regulating nucleolar number. Mechanistically, regulates the nucleolar levels of fibrillarin and nucleolin, two key players in pre-rRNA processing and ribosome assembly. {ECO:0000256|ARBA:ARBA00057078}. |
P08151 | GLI1 | S608 | GPS6 | Zinc finger protein GLI1 (Glioma-associated oncogene) (Oncogene GLI) | Acts as a transcriptional activator (PubMed:10806483, PubMed:19706761, PubMed:19878745, PubMed:24076122, PubMed:24217340, PubMed:24311597). Binds to the DNA consensus sequence 5'-GACCACCCA-3' (PubMed:2105456, PubMed:24217340, PubMed:8378770). Regulates the transcription of specific genes during normal development (PubMed:19706761). Plays a role in craniofacial development and digital development, as well as development of the central nervous system and gastrointestinal tract. Mediates SHH signaling (PubMed:19706761, PubMed:28973407). Plays a role in cell proliferation and differentiation via its role in SHH signaling (PubMed:11238441, PubMed:28973407). {ECO:0000269|PubMed:10806483, ECO:0000269|PubMed:11238441, ECO:0000269|PubMed:19706761, ECO:0000269|PubMed:19878745, ECO:0000269|PubMed:2105456, ECO:0000269|PubMed:24076122, ECO:0000269|PubMed:24217340, ECO:0000269|PubMed:24311597, ECO:0000269|PubMed:28973407, ECO:0000269|PubMed:8378770}.; FUNCTION: [Isoform 2]: Acts as a transcriptional activator, but activates a different set of genes than isoform 1. Activates expression of CD24, unlike isoform 1. Mediates SHH signaling. Promotes cancer cell migration. {ECO:0000269|PubMed:19706761}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-2025928 | Calcineurin activates NFAT | 0.000370 | 3.432 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 0.000548 | 3.261 |
R-HSA-525793 | Myogenesis | 0.000520 | 3.284 |
R-HSA-5607763 | CLEC7A (Dectin-1) induces NFAT activation | 0.001189 | 2.925 |
R-HSA-8941333 | RUNX2 regulates genes involved in differentiation of myeloid cells | 0.002187 | 2.660 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 0.001675 | 2.776 |
R-HSA-9931509 | Expression of BMAL (ARNTL), CLOCK, and NPAS2 | 0.001967 | 2.706 |
R-HSA-5635851 | GLI proteins bind promoters of Hh responsive genes to promote transcription | 0.003831 | 2.417 |
R-HSA-1640170 | Cell Cycle | 0.003980 | 2.400 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.002938 | 2.532 |
R-HSA-162582 | Signal Transduction | 0.003157 | 2.501 |
R-HSA-8939246 | RUNX1 regulates transcription of genes involved in differentiation of myeloid ce... | 0.007084 | 2.150 |
R-HSA-9909396 | Circadian clock | 0.007114 | 2.148 |
R-HSA-68962 | Activation of the pre-replicative complex | 0.008202 | 2.086 |
R-HSA-8939211 | ESR-mediated signaling | 0.009358 | 2.029 |
R-HSA-74160 | Gene expression (Transcription) | 0.009109 | 2.041 |
R-HSA-9707616 | Heme signaling | 0.008565 | 2.067 |
R-HSA-195721 | Signaling by WNT | 0.010741 | 1.969 |
R-HSA-191650 | Regulation of gap junction activity | 0.065577 | 1.183 |
R-HSA-8952158 | RUNX3 regulates BCL2L11 (BIM) transcription | 0.065577 | 1.183 |
R-HSA-5083630 | Defective LFNG causes SCDO3 | 0.065577 | 1.183 |
R-HSA-9017802 | Noncanonical activation of NOTCH3 | 0.086471 | 1.063 |
R-HSA-5688890 | Defective CSF2RA causes SMDP4 | 0.086471 | 1.063 |
R-HSA-9022537 | Loss of MECP2 binding ability to the NCoR/SMRT complex | 0.086471 | 1.063 |
R-HSA-5688849 | Defective CSF2RB causes SMDP5 | 0.086471 | 1.063 |
R-HSA-9933947 | Formation of the non-canonical BAF (ncBAF) complex | 0.016188 | 1.791 |
R-HSA-8931987 | RUNX1 regulates estrogen receptor mediated transcription | 0.106901 | 0.971 |
R-HSA-1912399 | Pre-NOTCH Processing in the Endoplasmic Reticulum | 0.106901 | 0.971 |
R-HSA-196025 | Formation of annular gap junctions | 0.116944 | 0.932 |
R-HSA-8875656 | MET receptor recycling | 0.116944 | 0.932 |
R-HSA-9768778 | Regulation of NPAS4 mRNA translation | 0.116944 | 0.932 |
R-HSA-9020958 | Interleukin-21 signaling | 0.126876 | 0.897 |
R-HSA-190873 | Gap junction degradation | 0.126876 | 0.897 |
R-HSA-9700645 | ALK mutants bind TKIs | 0.126876 | 0.897 |
R-HSA-8875555 | MET activates RAP1 and RAC1 | 0.136696 | 0.864 |
R-HSA-350054 | Notch-HLH transcription pathway | 0.040527 | 1.392 |
R-HSA-9759811 | Regulation of CDH11 mRNA translation by microRNAs | 0.146407 | 0.834 |
R-HSA-2514853 | Condensation of Prometaphase Chromosomes | 0.156008 | 0.807 |
R-HSA-2559584 | Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 0.174891 | 0.757 |
R-HSA-8948700 | Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 0.193353 | 0.714 |
R-HSA-9027284 | Erythropoietin activates RAS | 0.193353 | 0.714 |
R-HSA-5656121 | Translesion synthesis by POLI | 0.202430 | 0.694 |
R-HSA-5655862 | Translesion synthesis by POLK | 0.211405 | 0.675 |
R-HSA-190840 | Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | 0.220279 | 0.657 |
R-HSA-5651801 | PCNA-Dependent Long Patch Base Excision Repair | 0.229054 | 0.640 |
R-HSA-1912420 | Pre-NOTCH Processing in Golgi | 0.237731 | 0.624 |
R-HSA-9927418 | Developmental Lineage of Mammary Gland Luminal Epithelial Cells | 0.110335 | 0.957 |
R-HSA-9909620 | Regulation of PD-L1(CD274) translation | 0.246311 | 0.609 |
R-HSA-9934037 | Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | 0.246311 | 0.609 |
R-HSA-438066 | Unblocking of NMDA receptors, glutamate binding and activation | 0.263184 | 0.580 |
R-HSA-442982 | Ras activation upon Ca2+ influx through NMDA receptor | 0.263184 | 0.580 |
R-HSA-5696397 | Gap-filling DNA repair synthesis and ligation in GG-NER | 0.263184 | 0.580 |
R-HSA-9013507 | NOTCH3 Activation and Transmission of Signal to the Nucleus | 0.271479 | 0.566 |
R-HSA-76071 | RNA Polymerase III Transcription Initiation From Type 3 Promoter | 0.271479 | 0.566 |
R-HSA-383280 | Nuclear Receptor transcription pathway | 0.074730 | 1.127 |
R-HSA-8943723 | Regulation of PTEN mRNA translation | 0.279681 | 0.553 |
R-HSA-912526 | Interleukin receptor SHC signaling | 0.279681 | 0.553 |
R-HSA-9709570 | Impaired BRCA2 binding to RAD51 | 0.326999 | 0.485 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 0.191934 | 0.717 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 0.191934 | 0.717 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 0.334580 | 0.476 |
R-HSA-8854518 | AURKA Activation by TPX2 | 0.204198 | 0.690 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 0.342075 | 0.466 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 0.342075 | 0.466 |
R-HSA-9668328 | Sealing of the nuclear envelope (NE) by ESCRT-III | 0.356814 | 0.448 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 0.356814 | 0.448 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 0.356814 | 0.448 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 0.233108 | 0.632 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 0.233108 | 0.632 |
R-HSA-380287 | Centrosome maturation | 0.241420 | 0.617 |
R-HSA-1989781 | PPARA activates gene expression | 0.133901 | 0.873 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 0.270586 | 0.568 |
R-HSA-141424 | Amplification of signal from the kinetochores | 0.287252 | 0.542 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 0.287252 | 0.542 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 0.299728 | 0.523 |
R-HSA-400206 | Regulation of lipid metabolism by PPARalpha | 0.137909 | 0.860 |
R-HSA-9018519 | Estrogen-dependent gene expression | 0.030796 | 1.512 |
R-HSA-9614657 | FOXO-mediated transcription of cell death genes | 0.229054 | 0.640 |
R-HSA-9013508 | NOTCH3 Intracellular Domain Regulates Transcription | 0.334580 | 0.476 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.221988 | 0.654 |
R-HSA-5656169 | Termination of translesion DNA synthesis | 0.326999 | 0.485 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 0.308026 | 0.511 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 0.075553 | 1.122 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 0.075553 | 1.122 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 0.075553 | 1.122 |
R-HSA-110314 | Recognition of DNA damage by PCNA-containing replication complex | 0.287791 | 0.541 |
R-HSA-174411 | Polymerase switching on the C-strand of the telomere | 0.295810 | 0.529 |
R-HSA-9617828 | FOXO-mediated transcription of cell cycle genes | 0.263184 | 0.580 |
R-HSA-110312 | Translesion synthesis by REV1 | 0.193353 | 0.714 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 0.158150 | 0.801 |
R-HSA-8939245 | RUNX1 regulates transcription of genes involved in BCR signaling | 0.076083 | 1.119 |
R-HSA-9839394 | TGFBR3 expression | 0.048608 | 1.313 |
R-HSA-9931530 | Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | 0.165503 | 0.781 |
R-HSA-69166 | Removal of the Flap Intermediate | 0.184174 | 0.735 |
R-HSA-9931521 | The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CL... | 0.211405 | 0.675 |
R-HSA-174437 | Removal of the Flap Intermediate from the C-strand | 0.220279 | 0.657 |
R-HSA-110320 | Translesion Synthesis by POLH | 0.237731 | 0.624 |
R-HSA-73863 | RNA Polymerase I Transcription Termination | 0.311580 | 0.506 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.250904 | 0.600 |
R-HSA-3928664 | Ephrin signaling | 0.229054 | 0.640 |
R-HSA-4641265 | Repression of WNT target genes | 0.165503 | 0.781 |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 0.034060 | 1.468 |
R-HSA-426496 | Post-transcriptional silencing by small RNAs | 0.076083 | 1.119 |
R-HSA-9764562 | Regulation of CDH1 mRNA translation by microRNAs | 0.184174 | 0.735 |
R-HSA-190872 | Transport of connexons to the plasma membrane | 0.229054 | 0.640 |
R-HSA-450321 | JNK (c-Jun kinases) phosphorylation and activation mediated by activated human ... | 0.254795 | 0.594 |
R-HSA-9619483 | Activation of AMPK downstream of NMDARs | 0.319333 | 0.496 |
R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | 0.356814 | 0.448 |
R-HSA-512988 | Interleukin-3, Interleukin-5 and GM-CSF signaling | 0.110335 | 0.957 |
R-HSA-72172 | mRNA Splicing | 0.248510 | 0.605 |
R-HSA-9614399 | Regulation of localization of FOXO transcription factors | 0.146407 | 0.834 |
R-HSA-68877 | Mitotic Prometaphase | 0.034406 | 1.463 |
R-HSA-180024 | DARPP-32 events | 0.326999 | 0.485 |
R-HSA-8934593 | Regulation of RUNX1 Expression and Activity | 0.303740 | 0.517 |
R-HSA-4608870 | Asymmetric localization of PCP proteins | 0.121360 | 0.916 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 0.054469 | 1.264 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 0.046801 | 1.330 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 0.266417 | 0.574 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 0.031079 | 1.508 |
R-HSA-190827 | Transport of connexins along the secretory pathway | 0.033341 | 1.477 |
R-HSA-8875513 | MET interacts with TNS proteins | 0.054952 | 1.260 |
R-HSA-8964540 | Alanine metabolism | 0.065577 | 1.183 |
R-HSA-8939256 | RUNX1 regulates transcription of genes involved in WNT signaling | 0.096743 | 1.014 |
R-HSA-2470946 | Cohesin Loading onto Chromatin | 0.106901 | 0.971 |
R-HSA-446107 | Type I hemidesmosome assembly | 0.116944 | 0.932 |
R-HSA-428543 | Inactivation of CDC42 and RAC1 | 0.126876 | 0.897 |
R-HSA-9927426 | Developmental Lineage of Mammary Gland Alveolar Cells | 0.079113 | 1.102 |
R-HSA-8875878 | MET promotes cell motility | 0.092613 | 1.033 |
R-HSA-73980 | RNA Polymerase III Transcription Termination | 0.229054 | 0.640 |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | 0.114658 | 0.941 |
R-HSA-9924644 | Developmental Lineages of the Mammary Gland | 0.228959 | 0.640 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 0.262247 | 0.581 |
R-HSA-9009391 | Extra-nuclear estrogen signaling | 0.039187 | 1.407 |
R-HSA-174417 | Telomere C-strand (Lagging Strand) Synthesis | 0.106722 | 0.972 |
R-HSA-176187 | Activation of ATR in response to replication stress | 0.356814 | 0.448 |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | 0.027580 | 1.559 |
R-HSA-69183 | Processive synthesis on the lagging strand | 0.193353 | 0.714 |
R-HSA-9620244 | Long-term potentiation | 0.295810 | 0.529 |
R-HSA-174414 | Processive synthesis on the C-strand of the telomere | 0.311580 | 0.506 |
R-HSA-68886 | M Phase | 0.017044 | 1.768 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 0.171797 | 0.765 |
R-HSA-9930044 | Nuclear RNA decay | 0.072618 | 1.139 |
R-HSA-8939243 | RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not kno... | 0.072618 | 1.139 |
R-HSA-9615933 | Postmitotic nuclear pore complex (NPC) reformation | 0.303740 | 0.517 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 0.305010 | 0.516 |
R-HSA-9843745 | Adipogenesis | 0.086613 | 1.062 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 0.039629 | 1.402 |
R-HSA-157118 | Signaling by NOTCH | 0.076229 | 1.118 |
R-HSA-9841251 | Mitochondrial unfolded protein response (UPRmt) | 0.054290 | 1.265 |
R-HSA-5632684 | Hedgehog 'on' state | 0.224815 | 0.648 |
R-HSA-9856532 | Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | 0.237731 | 0.624 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 0.212422 | 0.673 |
R-HSA-212165 | Epigenetic regulation of gene expression | 0.095985 | 1.018 |
R-HSA-9932451 | SWI/SNF chromatin remodelers | 0.048608 | 1.313 |
R-HSA-9932444 | ATP-dependent chromatin remodelers | 0.048608 | 1.313 |
R-HSA-5693538 | Homology Directed Repair | 0.188595 | 0.724 |
R-HSA-69002 | DNA Replication Pre-Initiation | 0.158150 | 0.801 |
R-HSA-190704 | Oligomerization of connexins into connexons | 0.033341 | 1.477 |
R-HSA-9729555 | Sensory perception of sour taste | 0.065577 | 1.183 |
R-HSA-9623433 | NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | 0.156008 | 0.807 |
R-HSA-430039 | mRNA decay by 5' to 3' exoribonuclease | 0.211405 | 0.675 |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | 0.356814 | 0.448 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 0.278922 | 0.555 |
R-HSA-68875 | Mitotic Prophase | 0.194287 | 0.712 |
R-HSA-9006335 | Signaling by Erythropoietin | 0.326999 | 0.485 |
R-HSA-1257604 | PIP3 activates AKT signaling | 0.148507 | 0.828 |
R-HSA-110373 | Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 0.303740 | 0.517 |
R-HSA-5610787 | Hedgehog 'off' state | 0.131971 | 0.880 |
R-HSA-749476 | RNA Polymerase III Abortive And Retractive Initiation | 0.085781 | 1.067 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 0.167743 | 0.775 |
R-HSA-76046 | RNA Polymerase III Transcription Initiation | 0.334580 | 0.476 |
R-HSA-5687613 | Diseases associated with surfactant metabolism | 0.165503 | 0.781 |
R-HSA-9022692 | Regulation of MECP2 expression and activity | 0.072618 | 1.139 |
R-HSA-912631 | Regulation of signaling by CBL | 0.237731 | 0.624 |
R-HSA-180786 | Extension of Telomeres | 0.175750 | 0.755 |
R-HSA-6784531 | tRNA processing in the nucleus | 0.187869 | 0.726 |
R-HSA-442742 | CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 0.356814 | 0.448 |
R-HSA-5358351 | Signaling by Hedgehog | 0.256199 | 0.591 |
R-HSA-74158 | RNA Polymerase III Transcription | 0.085781 | 1.067 |
R-HSA-69186 | Lagging Strand Synthesis | 0.254795 | 0.594 |
R-HSA-8863678 | Neurodegenerative Diseases | 0.287791 | 0.541 |
R-HSA-8862803 | Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's dis... | 0.287791 | 0.541 |
R-HSA-6783310 | Fanconi Anemia Pathway | 0.121360 | 0.916 |
R-HSA-9839373 | Signaling by TGFBR3 | 0.125094 | 0.903 |
R-HSA-9705677 | SARS-CoV-2 targets PDZ proteins in cell-cell junction | 0.065577 | 1.183 |
R-HSA-389542 | NADPH regeneration | 0.096743 | 1.014 |
R-HSA-198693 | AKT phosphorylates targets in the nucleus | 0.126876 | 0.897 |
R-HSA-68884 | Mitotic Telophase/Cytokinesis | 0.156008 | 0.807 |
R-HSA-879415 | Advanced glycosylation endproduct receptor signaling | 0.165503 | 0.781 |
R-HSA-9945266 | Differentiation of T cells | 0.202430 | 0.694 |
R-HSA-9942503 | Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | 0.202430 | 0.694 |
R-HSA-9617324 | Negative regulation of NMDA receptor-mediated neuronal transmission | 0.263184 | 0.580 |
R-HSA-9029569 | NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflu... | 0.171739 | 0.765 |
R-HSA-9734009 | Defective Intrinsic Pathway for Apoptosis | 0.311580 | 0.506 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 0.208305 | 0.681 |
R-HSA-69473 | G2/M DNA damage checkpoint | 0.237262 | 0.625 |
R-HSA-9006925 | Intracellular signaling by second messengers | 0.227649 | 0.643 |
R-HSA-157579 | Telomere Maintenance | 0.345087 | 0.462 |
R-HSA-170968 | Frs2-mediated activation | 0.174891 | 0.757 |
R-HSA-9662834 | CD163 mediating an anti-inflammatory response | 0.146407 | 0.834 |
R-HSA-9617629 | Regulation of FOXO transcriptional activity by acetylation | 0.165503 | 0.781 |
R-HSA-5358606 | Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 0.220279 | 0.657 |
R-HSA-69306 | DNA Replication | 0.305010 | 0.516 |
R-HSA-9005895 | Pervasive developmental disorders | 0.165503 | 0.781 |
R-HSA-9697154 | Disorders of Nervous System Development | 0.165503 | 0.781 |
R-HSA-9005891 | Loss of function of MECP2 in Rett syndrome | 0.165503 | 0.781 |
R-HSA-9933937 | Formation of the canonical BAF (cBAF) complex | 0.184174 | 0.735 |
R-HSA-9933946 | Formation of the embryonic stem cell BAF (esBAF) complex | 0.193353 | 0.714 |
R-HSA-5358565 | Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 0.220279 | 0.657 |
R-HSA-9824594 | Regulation of MITF-M-dependent genes involved in apoptosis | 0.254795 | 0.594 |
R-HSA-200425 | Carnitine shuttle | 0.279681 | 0.553 |
R-HSA-156584 | Cytosolic sulfonation of small molecules | 0.144151 | 0.841 |
R-HSA-69190 | DNA strand elongation | 0.349486 | 0.457 |
R-HSA-9024446 | NR1H2 and NR1H3-mediated signaling | 0.249745 | 0.603 |
R-HSA-8953854 | Metabolism of RNA | 0.262855 | 0.580 |
R-HSA-451927 | Interleukin-2 family signaling | 0.099596 | 1.002 |
R-HSA-9768759 | Regulation of NPAS4 gene expression | 0.220279 | 0.657 |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | 0.180142 | 0.744 |
R-HSA-438064 | Post NMDA receptor activation events | 0.295573 | 0.529 |
R-HSA-5358508 | Mismatch Repair | 0.229054 | 0.640 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 0.074730 | 1.127 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 0.137078 | 0.863 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 0.080529 | 1.094 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.030225 | 1.520 |
R-HSA-8866910 | TFAP2 (AP-2) family regulates transcription of growth factors and their receptor... | 0.023989 | 1.620 |
R-HSA-9933939 | Formation of the polybromo-BAF (pBAF) complex | 0.184174 | 0.735 |
R-HSA-9675151 | Disorders of Developmental Biology | 0.211405 | 0.675 |
R-HSA-4419969 | Depolymerization of the Nuclear Lamina | 0.229054 | 0.640 |
R-HSA-9634638 | Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 0.279681 | 0.553 |
R-HSA-4086400 | PCP/CE pathway | 0.253911 | 0.595 |
R-HSA-212436 | Generic Transcription Pathway | 0.031912 | 1.496 |
R-HSA-4839726 | Chromatin organization | 0.086323 | 1.064 |
R-HSA-169893 | Prolonged ERK activation events | 0.202430 | 0.694 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 0.096682 | 1.015 |
R-HSA-6806834 | Signaling by MET | 0.262247 | 0.581 |
R-HSA-9659379 | Sensory processing of sound | 0.258078 | 0.588 |
R-HSA-8877330 | RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | 0.174891 | 0.757 |
R-HSA-4086398 | Ca2+ pathway | 0.233108 | 0.632 |
R-HSA-9764725 | Negative Regulation of CDH1 Gene Transcription | 0.042651 | 1.370 |
R-HSA-2995383 | Initiation of Nuclear Envelope (NE) Reformation | 0.263184 | 0.580 |
R-HSA-9759475 | Regulation of CDH11 Expression and Function | 0.326999 | 0.485 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 0.212422 | 0.673 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 0.202904 | 0.693 |
R-HSA-9031628 | NGF-stimulated transcription | 0.026239 | 1.581 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 0.082426 | 1.084 |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | 0.059420 | 1.226 |
R-HSA-3214847 | HATs acetylate histones | 0.353242 | 0.452 |
R-HSA-69206 | G1/S Transition | 0.075553 | 1.122 |
R-HSA-428643 | Organic anion transport by SLC5/17/25 transporters | 0.229054 | 0.640 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 0.163764 | 0.786 |
R-HSA-186763 | Downstream signal transduction | 0.342075 | 0.466 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 0.283088 | 0.548 |
R-HSA-9764260 | Regulation of Expression and Function of Type II Classical Cadherins | 0.356814 | 0.448 |
R-HSA-159418 | Recycling of bile acids and salts | 0.356814 | 0.448 |
R-HSA-3247509 | Chromatin modifying enzymes | 0.162062 | 0.790 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 0.027580 | 1.559 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 0.340140 | 0.468 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 0.226754 | 0.644 |
R-HSA-9933387 | RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | 0.063226 | 1.199 |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | 0.136455 | 0.865 |
R-HSA-2173795 | Downregulation of SMAD2/3:SMAD4 transcriptional activity | 0.349486 | 0.457 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 0.173813 | 0.760 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 0.173813 | 0.760 |
R-HSA-9764560 | Regulation of CDH1 Gene Transcription | 0.059420 | 1.226 |
R-HSA-446728 | Cell junction organization | 0.248800 | 0.604 |
R-HSA-198725 | Nuclear Events (kinase and transcription factor activation) | 0.063094 | 1.200 |
R-HSA-264870 | Caspase-mediated cleavage of cytoskeletal proteins | 0.126876 | 0.897 |
R-HSA-6804759 | Regulation of TP53 Activity through Association with Co-factors | 0.174891 | 0.757 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 0.226293 | 0.645 |
R-HSA-2559583 | Cellular Senescence | 0.189456 | 0.722 |
R-HSA-418990 | Adherens junctions interactions | 0.283175 | 0.548 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 0.063856 | 1.195 |
R-HSA-1500931 | Cell-Cell communication | 0.331256 | 0.480 |
R-HSA-1181150 | Signaling by NODAL | 0.246311 | 0.609 |
R-HSA-193807 | Synthesis of bile acids and bile salts via 27-hydroxycholesterol | 0.311580 | 0.506 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 0.116487 | 0.934 |
R-HSA-187037 | Signaling by NTRK1 (TRKA) | 0.080200 | 1.096 |
R-HSA-9022699 | MECP2 regulates neuronal receptors and channels | 0.051421 | 1.289 |
R-HSA-69205 | G1/S-Specific Transcription | 0.085781 | 1.067 |
R-HSA-2426168 | Activation of gene expression by SREBF (SREBP) | 0.191934 | 0.717 |
R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 0.117655 | 0.929 |
R-HSA-449147 | Signaling by Interleukins | 0.308971 | 0.510 |
R-HSA-2151201 | Transcriptional activation of mitochondrial biogenesis | 0.080879 | 1.092 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 0.065262 | 1.185 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 0.243634 | 0.613 |
R-HSA-9006936 | Signaling by TGFB family members | 0.326532 | 0.486 |
R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) | 0.258078 | 0.588 |
R-HSA-2262752 | Cellular responses to stress | 0.287225 | 0.542 |
R-HSA-1368108 | BMAL1:CLOCK,NPAS2 activates circadian expression | 0.079113 | 1.102 |
R-HSA-5674400 | Constitutive Signaling by AKT1 E17K in Cancer | 0.279681 | 0.553 |
R-HSA-9931510 | Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock gene... | 0.303740 | 0.517 |
R-HSA-1592230 | Mitochondrial biogenesis | 0.185766 | 0.731 |
R-HSA-8953897 | Cellular responses to stimuli | 0.339898 | 0.469 |
R-HSA-1980143 | Signaling by NOTCH1 | 0.245581 | 0.610 |
R-HSA-5210891 | Uptake and function of anthrax toxins | 0.220279 | 0.657 |
R-HSA-166520 | Signaling by NTRKs | 0.120267 | 0.920 |
R-HSA-9707564 | Cytoprotection by HMOX1 | 0.085097 | 1.070 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 0.121968 | 0.914 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 0.320380 | 0.494 |
R-HSA-1266695 | Interleukin-7 signaling | 0.295810 | 0.529 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 0.187869 | 0.726 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 0.356814 | 0.448 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 0.349486 | 0.457 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 0.217249 | 0.663 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 0.357307 | 0.447 |
R-HSA-70171 | Glycolysis | 0.357307 | 0.447 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 0.360328 | 0.443 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 0.363391 | 0.440 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 0.364061 | 0.439 |
R-HSA-390471 | Association of TriC/CCT with target proteins during biosynthesis | 0.364061 | 0.439 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 0.364061 | 0.439 |
R-HSA-5693537 | Resolution of D-Loop Structures | 0.364061 | 0.439 |
R-HSA-9619665 | EGR2 and SOX10-mediated initiation of Schwann cell myelination | 0.364061 | 0.439 |
R-HSA-114508 | Effects of PIP2 hydrolysis | 0.364061 | 0.439 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 0.365408 | 0.437 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 0.365408 | 0.437 |
R-HSA-1483255 | PI Metabolism | 0.365408 | 0.437 |
R-HSA-421270 | Cell-cell junction organization | 0.366974 | 0.435 |
R-HSA-5696400 | Dual Incision in GG-NER | 0.371226 | 0.430 |
R-HSA-190861 | Gap junction assembly | 0.371226 | 0.430 |
R-HSA-180746 | Nuclear import of Rev protein | 0.371226 | 0.430 |
R-HSA-9701190 | Defective homologous recombination repair (HRR) due to BRCA2 loss of function | 0.371226 | 0.430 |
R-HSA-9675136 | Diseases of DNA Double-Strand Break Repair | 0.371226 | 0.430 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 0.377487 | 0.423 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 0.377487 | 0.423 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 0.378310 | 0.422 |
R-HSA-2559585 | Oncogene Induced Senescence | 0.378310 | 0.422 |
R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange | 0.378310 | 0.422 |
R-HSA-187687 | Signalling to ERKs | 0.378310 | 0.422 |
R-HSA-69620 | Cell Cycle Checkpoints | 0.384824 | 0.415 |
R-HSA-3371511 | HSF1 activation | 0.385316 | 0.414 |
R-HSA-8853659 | RET signaling | 0.385316 | 0.414 |
R-HSA-69239 | Synthesis of DNA | 0.389471 | 0.410 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 0.389471 | 0.410 |
R-HSA-9700206 | Signaling by ALK in cancer | 0.389471 | 0.410 |
R-HSA-211000 | Gene Silencing by RNA | 0.389471 | 0.410 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 0.392242 | 0.406 |
R-HSA-5689896 | Ovarian tumor domain proteases | 0.392242 | 0.406 |
R-HSA-9734779 | Developmental Cell Lineages of the Integumentary System | 0.393443 | 0.405 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 0.399092 | 0.399 |
R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | 0.399092 | 0.399 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.403157 | 0.395 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 0.405864 | 0.392 |
R-HSA-8953750 | Transcriptional Regulation by E2F6 | 0.405864 | 0.392 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 0.405864 | 0.392 |
R-HSA-69275 | G2/M Transition | 0.408989 | 0.388 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 0.412561 | 0.385 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 0.412561 | 0.385 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 0.412561 | 0.385 |
R-HSA-1251985 | Nuclear signaling by ERBB4 | 0.412561 | 0.385 |
R-HSA-5696395 | Formation of Incision Complex in GG-NER | 0.412561 | 0.385 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 0.415003 | 0.382 |
R-HSA-453274 | Mitotic G2-G2/M phases | 0.415003 | 0.382 |
R-HSA-110313 | Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA templa... | 0.419182 | 0.378 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 0.419182 | 0.378 |
R-HSA-8853884 | Transcriptional Regulation by VENTX | 0.419182 | 0.378 |
R-HSA-73933 | Resolution of Abasic Sites (AP sites) | 0.419182 | 0.378 |
R-HSA-3214841 | PKMTs methylate histone lysines | 0.419182 | 0.378 |
R-HSA-9607240 | FLT3 Signaling | 0.419182 | 0.378 |
R-HSA-5625886 | Activated PKN1 stimulates transcription of AR (androgen receptor) regulated gene... | 0.419182 | 0.378 |
R-HSA-5610780 | Degradation of GLI1 by the proteasome | 0.425729 | 0.371 |
R-HSA-9615017 | FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 0.425729 | 0.371 |
R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors | 0.425729 | 0.371 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.426428 | 0.370 |
R-HSA-73762 | RNA Polymerase I Transcription Initiation | 0.432203 | 0.364 |
R-HSA-70326 | Glucose metabolism | 0.436319 | 0.360 |
R-HSA-1433557 | Signaling by SCF-KIT | 0.438604 | 0.358 |
R-HSA-190828 | Gap junction trafficking | 0.444934 | 0.352 |
R-HSA-3214858 | RMTs methylate histone arginines | 0.444934 | 0.352 |
R-HSA-5683826 | Surfactant metabolism | 0.444934 | 0.352 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 0.451192 | 0.346 |
R-HSA-9824585 | Regulation of MITF-M-dependent genes involved in pigmentation | 0.451192 | 0.346 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 0.451507 | 0.345 |
R-HSA-73886 | Chromosome Maintenance | 0.451507 | 0.345 |
R-HSA-3371556 | Cellular response to heat stress | 0.451507 | 0.345 |
R-HSA-2299718 | Condensation of Prophase Chromosomes | 0.457380 | 0.340 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 0.457380 | 0.340 |
R-HSA-9675135 | Diseases of DNA repair | 0.457380 | 0.340 |
R-HSA-75153 | Apoptotic execution phase | 0.457380 | 0.340 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 0.469550 | 0.328 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 0.471155 | 0.327 |
R-HSA-73893 | DNA Damage Bypass | 0.475532 | 0.323 |
R-HSA-157858 | Gap junction trafficking and regulation | 0.475532 | 0.323 |
R-HSA-69481 | G2/M Checkpoints | 0.477520 | 0.321 |
R-HSA-1234176 | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 0.487296 | 0.312 |
R-HSA-912446 | Meiotic recombination | 0.487296 | 0.312 |
R-HSA-72187 | mRNA 3'-end processing | 0.493079 | 0.307 |
R-HSA-73772 | RNA Polymerase I Promoter Escape | 0.493079 | 0.307 |
R-HSA-68949 | Orc1 removal from chromatin | 0.493079 | 0.307 |
R-HSA-6794361 | Neurexins and neuroligins | 0.493079 | 0.307 |
R-HSA-9634815 | Transcriptional Regulation by NPAS4 | 0.493079 | 0.307 |
R-HSA-5339562 | Uptake and actions of bacterial toxins | 0.493079 | 0.307 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 0.498798 | 0.302 |
R-HSA-68882 | Mitotic Anaphase | 0.499556 | 0.301 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 0.502366 | 0.299 |
R-HSA-9012852 | Signaling by NOTCH3 | 0.510043 | 0.292 |
R-HSA-6811436 | COPI-independent Golgi-to-ER retrograde traffic | 0.510043 | 0.292 |
R-HSA-3214815 | HDACs deacetylate histones | 0.510043 | 0.292 |
R-HSA-6782210 | Gap-filling DNA repair synthesis and ligation in TC-NER | 0.515571 | 0.288 |
R-HSA-193648 | NRAGE signals death through JNK | 0.515571 | 0.288 |
R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 0.515571 | 0.288 |
R-HSA-6782135 | Dual incision in TC-NER | 0.526442 | 0.279 |
R-HSA-6807070 | PTEN Regulation | 0.527233 | 0.278 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 0.531786 | 0.274 |
R-HSA-191859 | snRNP Assembly | 0.531786 | 0.274 |
R-HSA-194441 | Metabolism of non-coding RNA | 0.531786 | 0.274 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 0.531786 | 0.274 |
R-HSA-2022090 | Assembly of collagen fibrils and other multimeric structures | 0.531786 | 0.274 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 0.537070 | 0.270 |
R-HSA-8943724 | Regulation of PTEN gene transcription | 0.537070 | 0.270 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 0.537070 | 0.270 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 0.537070 | 0.270 |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 0.537070 | 0.270 |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 0.537070 | 0.270 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 0.537070 | 0.270 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 0.542295 | 0.266 |
R-HSA-73856 | RNA Polymerase II Transcription Termination | 0.542295 | 0.266 |
R-HSA-2428928 | IRS-related events triggered by IGF1R | 0.542295 | 0.266 |
R-HSA-211976 | Endogenous sterols | 0.542295 | 0.266 |
R-HSA-8939902 | Regulation of RUNX2 expression and activity | 0.542295 | 0.266 |
R-HSA-450294 | MAP kinase activation | 0.542295 | 0.266 |
R-HSA-72312 | rRNA processing | 0.543521 | 0.265 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 0.547461 | 0.262 |
R-HSA-186797 | Signaling by PDGF | 0.547461 | 0.262 |
R-HSA-6790901 | rRNA modification in the nucleus and cytosol | 0.552569 | 0.258 |
R-HSA-2428924 | IGF1R signaling cascade | 0.557620 | 0.254 |
R-HSA-69242 | S Phase | 0.560746 | 0.251 |
R-HSA-1234174 | Cellular response to hypoxia | 0.562614 | 0.250 |
R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 0.562614 | 0.250 |
R-HSA-9856651 | MITF-M-dependent gene expression | 0.567243 | 0.246 |
R-HSA-5693606 | DNA Double Strand Break Response | 0.572435 | 0.242 |
R-HSA-193368 | Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 0.572435 | 0.242 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 0.580031 | 0.237 |
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | 0.586756 | 0.232 |
R-HSA-75105 | Fatty acyl-CoA biosynthesis | 0.586756 | 0.232 |
R-HSA-204005 | COPII-mediated vesicle transport | 0.586756 | 0.232 |
R-HSA-448424 | Interleukin-17 signaling | 0.586756 | 0.232 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 0.591423 | 0.228 |
R-HSA-427413 | NoRC negatively regulates rRNA expression | 0.591423 | 0.228 |
R-HSA-3906995 | Diseases associated with O-glycosylation of proteins | 0.591423 | 0.228 |
R-HSA-8978934 | Metabolism of cofactors | 0.591423 | 0.228 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 0.596037 | 0.225 |
R-HSA-5683057 | MAPK family signaling cascades | 0.597371 | 0.224 |
R-HSA-5633007 | Regulation of TP53 Activity | 0.598691 | 0.223 |
R-HSA-69052 | Switching of origins to a post-replicative state | 0.600600 | 0.221 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 0.600600 | 0.221 |
R-HSA-1236394 | Signaling by ERBB4 | 0.605111 | 0.218 |
R-HSA-6781827 | Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 0.609572 | 0.215 |
R-HSA-71403 | Citric acid cycle (TCA cycle) | 0.609572 | 0.215 |
R-HSA-1169408 | ISG15 antiviral mechanism | 0.609572 | 0.215 |
R-HSA-2467813 | Separation of Sister Chromatids | 0.610784 | 0.214 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 0.613983 | 0.212 |
R-HSA-73864 | RNA Polymerase I Transcription | 0.622656 | 0.206 |
R-HSA-9955298 | SLC-mediated transport of organic anions | 0.622656 | 0.206 |
R-HSA-416482 | G alpha (12/13) signalling events | 0.622656 | 0.206 |
R-HSA-5250941 | Negative epigenetic regulation of rRNA expression | 0.631135 | 0.200 |
R-HSA-9833482 | PKR-mediated signaling | 0.631135 | 0.200 |
R-HSA-72306 | tRNA processing | 0.631279 | 0.200 |
R-HSA-9711123 | Cellular response to chemical stress | 0.633781 | 0.198 |
R-HSA-5696399 | Global Genome Nucleotide Excision Repair (GG-NER) | 0.647529 | 0.189 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 0.647529 | 0.189 |
R-HSA-1500620 | Meiosis | 0.651513 | 0.186 |
R-HSA-6794362 | Protein-protein interactions at synapses | 0.651513 | 0.186 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 0.659348 | 0.181 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 0.659348 | 0.181 |
R-HSA-390466 | Chaperonin-mediated protein folding | 0.663199 | 0.178 |
R-HSA-70268 | Pyruvate metabolism | 0.663199 | 0.178 |
R-HSA-9645723 | Diseases of programmed cell death | 0.667007 | 0.176 |
R-HSA-73884 | Base Excision Repair | 0.674494 | 0.171 |
R-HSA-5617833 | Cilium Assembly | 0.685210 | 0.164 |
R-HSA-2682334 | EPH-Ephrin signaling | 0.685413 | 0.164 |
R-HSA-391251 | Protein folding | 0.685413 | 0.164 |
R-HSA-68867 | Assembly of the pre-replicative complex | 0.688971 | 0.162 |
R-HSA-1474290 | Collagen formation | 0.692489 | 0.160 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 0.699149 | 0.155 |
R-HSA-9609690 | HCMV Early Events | 0.700084 | 0.155 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 0.706170 | 0.151 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 0.706170 | 0.151 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 0.709494 | 0.149 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 0.709494 | 0.149 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 0.709494 | 0.149 |
R-HSA-9614085 | FOXO-mediated transcription | 0.712782 | 0.147 |
R-HSA-192105 | Synthesis of bile acids and bile salts | 0.712782 | 0.147 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 0.712782 | 0.147 |
R-HSA-9842860 | Regulation of endogenous retroelements | 0.722423 | 0.141 |
R-HSA-111885 | Opioid Signalling | 0.728670 | 0.137 |
R-HSA-9833110 | RSV-host interactions | 0.731742 | 0.136 |
R-HSA-5696398 | Nucleotide Excision Repair | 0.734778 | 0.134 |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | 0.734778 | 0.134 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 0.739097 | 0.131 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 0.741252 | 0.130 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 0.743685 | 0.129 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 0.746587 | 0.127 |
R-HSA-194068 | Bile acid and bile salt metabolism | 0.749457 | 0.125 |
R-HSA-937061 | TRIF (TICAM1)-mediated TLR4 signaling | 0.749457 | 0.125 |
R-HSA-166166 | MyD88-independent TLR4 cascade | 0.749457 | 0.125 |
R-HSA-1483249 | Inositol phosphate metabolism | 0.755099 | 0.122 |
R-HSA-2871796 | FCERI mediated MAPK activation | 0.755099 | 0.122 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 0.757873 | 0.120 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 0.760615 | 0.119 |
R-HSA-5628897 | TP53 Regulates Metabolic Genes | 0.766008 | 0.116 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 0.766008 | 0.116 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 0.771798 | 0.112 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 0.778966 | 0.108 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 0.778966 | 0.108 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 0.786396 | 0.104 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 0.786396 | 0.104 |
R-HSA-2132295 | MHC class II antigen presentation | 0.788817 | 0.103 |
R-HSA-162909 | Host Interactions of HIV factors | 0.791211 | 0.102 |
R-HSA-6798695 | Neutrophil degranulation | 0.791275 | 0.102 |
R-HSA-156580 | Phase II - Conjugation of compounds | 0.792167 | 0.101 |
R-HSA-73894 | DNA Repair | 0.805434 | 0.094 |
R-HSA-1474165 | Reproduction | 0.809414 | 0.092 |
R-HSA-9609646 | HCMV Infection | 0.810923 | 0.091 |
R-HSA-9717189 | Sensory perception of taste | 0.811576 | 0.091 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 0.813713 | 0.090 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 0.826039 | 0.083 |
R-HSA-9734767 | Developmental Cell Lineages | 0.831143 | 0.080 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 0.831894 | 0.080 |
R-HSA-9664417 | Leishmania phagocytosis | 0.831894 | 0.080 |
R-HSA-9664407 | Parasite infection | 0.831894 | 0.080 |
R-HSA-2029482 | Regulation of actin dynamics for phagocytic cup formation | 0.833802 | 0.079 |
R-HSA-1632852 | Macroautophagy | 0.833802 | 0.079 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 0.837553 | 0.077 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 0.837553 | 0.077 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 0.846567 | 0.072 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 0.848309 | 0.071 |
R-HSA-9824443 | Parasitic Infection Pathways | 0.855937 | 0.068 |
R-HSA-9658195 | Leishmania infection | 0.855937 | 0.068 |
R-HSA-73887 | Death Receptor Signaling | 0.858357 | 0.066 |
R-HSA-1266738 | Developmental Biology | 0.859810 | 0.066 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 0.859966 | 0.066 |
R-HSA-9612973 | Autophagy | 0.861556 | 0.065 |
R-HSA-9610379 | HCMV Late Events | 0.863129 | 0.064 |
R-HSA-162587 | HIV Life Cycle | 0.863129 | 0.064 |
R-HSA-5673001 | RAF/MAP kinase cascade | 0.865858 | 0.063 |
R-HSA-109581 | Apoptosis | 0.870731 | 0.060 |
R-HSA-1483257 | Phospholipid metabolism | 0.872885 | 0.059 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 0.874023 | 0.058 |
R-HSA-211897 | Cytochrome P450 - arranged by substrate type | 0.877913 | 0.057 |
R-HSA-5619102 | SLC transporter disorders | 0.877913 | 0.057 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 0.886009 | 0.053 |
R-HSA-9662851 | Anti-inflammatory response favouring Leishmania parasite infection | 0.887305 | 0.052 |
R-HSA-9664433 | Leishmania parasite growth and survival | 0.887305 | 0.052 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 0.888587 | 0.051 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 0.889854 | 0.051 |
R-HSA-168255 | Influenza Infection | 0.894781 | 0.048 |
R-HSA-3781865 | Diseases of glycosylation | 0.900633 | 0.045 |
R-HSA-112315 | Transmission across Chemical Synapses | 0.901425 | 0.045 |
R-HSA-8957322 | Metabolism of steroids | 0.902325 | 0.045 |
R-HSA-168898 | Toll-like Receptor Cascades | 0.908286 | 0.042 |
R-HSA-9675108 | Nervous system development | 0.912238 | 0.040 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 0.916504 | 0.038 |
R-HSA-112316 | Neuronal System | 0.916531 | 0.038 |
R-HSA-389948 | Co-inhibition by PD-1 | 0.917270 | 0.038 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 0.917270 | 0.038 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 0.919145 | 0.037 |
R-HSA-376176 | Signaling by ROBO receptors | 0.920066 | 0.036 |
R-HSA-9694516 | SARS-CoV-2 Infection | 0.922489 | 0.035 |
R-HSA-5357801 | Programmed Cell Death | 0.922768 | 0.035 |
R-HSA-162906 | HIV Infection | 0.939992 | 0.027 |
R-HSA-913531 | Interferon Signaling | 0.944244 | 0.025 |
R-HSA-211859 | Biological oxidations | 0.947163 | 0.024 |
R-HSA-5619115 | Disorders of transmembrane transporters | 0.952308 | 0.021 |
R-HSA-422475 | Axon guidance | 0.956203 | 0.019 |
R-HSA-5688426 | Deubiquitination | 0.956499 | 0.019 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 0.956996 | 0.019 |
R-HSA-416476 | G alpha (q) signalling events | 0.960776 | 0.017 |
R-HSA-5668914 | Diseases of metabolism | 0.963458 | 0.016 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 0.965041 | 0.015 |
R-HSA-211945 | Phase I - Functionalization of compounds | 0.966614 | 0.015 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 0.968117 | 0.014 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 0.972193 | 0.012 |
R-HSA-168249 | Innate Immune System | 0.972435 | 0.012 |
R-HSA-168256 | Immune System | 0.979571 | 0.009 |
R-HSA-1474244 | Extracellular matrix organization | 0.981884 | 0.008 |
R-HSA-199991 | Membrane Trafficking | 0.982367 | 0.008 |
R-HSA-1280218 | Adaptive Immune System | 0.983214 | 0.007 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 0.987632 | 0.005 |
R-HSA-9679506 | SARS-CoV Infections | 0.989760 | 0.004 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 0.990190 | 0.004 |
R-HSA-9824439 | Bacterial Infection Pathways | 0.990955 | 0.004 |
R-HSA-425407 | SLC-mediated transmembrane transport | 0.991660 | 0.004 |
R-HSA-418594 | G alpha (i) signalling events | 0.992574 | 0.003 |
R-HSA-8978868 | Fatty acid metabolism | 0.992574 | 0.003 |
R-HSA-446203 | Asparagine N-linked glycosylation | 0.993762 | 0.003 |
R-HSA-388396 | GPCR downstream signalling | 0.994536 | 0.002 |
R-HSA-5653656 | Vesicle-mediated transport | 0.996054 | 0.002 |
R-HSA-372790 | Signaling by GPCR | 0.997547 | 0.001 |
R-HSA-556833 | Metabolism of lipids | 0.998636 | 0.001 |
R-HSA-597592 | Post-translational protein modification | 0.999024 | 0.000 |
R-HSA-109582 | Hemostasis | 0.999065 | 0.000 |
R-HSA-9824446 | Viral Infection Pathways | 0.999203 | 0.000 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 0.999370 | 0.000 |
R-HSA-5663205 | Infectious disease | 0.999765 | 0.000 |
R-HSA-1643685 | Disease | 0.999916 | 0.000 |
R-HSA-9709957 | Sensory Perception | 0.999950 | 0.000 |
R-HSA-392499 | Metabolism of proteins | 0.999986 | 0.000 |
R-HSA-382551 | Transport of small molecules | 0.999992 | 0.000 |
R-HSA-1430728 | Metabolism | 1.000000 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
KIS |
0.791 | 0.645 | 1 | 0.812 |
CDK18 |
0.783 | 0.659 | 1 | 0.883 |
HIPK2 |
0.783 | 0.637 | 1 | 0.851 |
P38G |
0.777 | 0.676 | 1 | 0.915 |
CDK19 |
0.777 | 0.642 | 1 | 0.865 |
CDK3 |
0.776 | 0.581 | 1 | 0.904 |
CDK17 |
0.775 | 0.654 | 1 | 0.909 |
CDK1 |
0.770 | 0.621 | 1 | 0.870 |
JNK2 |
0.768 | 0.683 | 1 | 0.881 |
CDK8 |
0.768 | 0.634 | 1 | 0.834 |
CDK5 |
0.766 | 0.617 | 1 | 0.817 |
CDK16 |
0.765 | 0.616 | 1 | 0.897 |
CDK13 |
0.765 | 0.638 | 1 | 0.860 |
P38D |
0.764 | 0.652 | 1 | 0.901 |
CDK7 |
0.764 | 0.620 | 1 | 0.842 |
CDK12 |
0.763 | 0.639 | 1 | 0.876 |
ERK1 |
0.762 | 0.631 | 1 | 0.860 |
P38B |
0.761 | 0.646 | 1 | 0.846 |
DYRK2 |
0.757 | 0.600 | 1 | 0.773 |
JNK3 |
0.757 | 0.663 | 1 | 0.853 |
CDK10 |
0.756 | 0.575 | 1 | 0.868 |
HIPK4 |
0.756 | 0.468 | 1 | 0.574 |
HIPK1 |
0.755 | 0.565 | 1 | 0.762 |
CLK3 |
0.755 | 0.400 | 1 | 0.566 |
CDK9 |
0.754 | 0.621 | 1 | 0.852 |
DYRK4 |
0.754 | 0.601 | 1 | 0.864 |
P38A |
0.751 | 0.625 | 1 | 0.785 |
CDK14 |
0.749 | 0.599 | 1 | 0.853 |
DYRK1B |
0.744 | 0.561 | 1 | 0.833 |
SRPK1 |
0.743 | 0.291 | -3 | 0.707 |
HIPK3 |
0.742 | 0.555 | 1 | 0.728 |
CDK6 |
0.741 | 0.588 | 1 | 0.864 |
JNK1 |
0.740 | 0.591 | 1 | 0.884 |
CLK2 |
0.739 | 0.332 | -3 | 0.699 |
NLK |
0.738 | 0.545 | 1 | 0.598 |
CDK4 |
0.735 | 0.596 | 1 | 0.884 |
ERK2 |
0.735 | 0.591 | 1 | 0.819 |
CDK2 |
0.734 | 0.465 | 1 | 0.758 |
DYRK1A |
0.732 | 0.470 | 1 | 0.747 |
CLK1 |
0.730 | 0.334 | -3 | 0.684 |
MAK |
0.728 | 0.406 | -2 | 0.663 |
MTOR |
0.728 | 0.256 | 1 | 0.388 |
ERK5 |
0.726 | 0.309 | 1 | 0.508 |
SRPK2 |
0.726 | 0.217 | -3 | 0.629 |
CLK4 |
0.723 | 0.297 | -3 | 0.713 |
PRP4 |
0.723 | 0.428 | -3 | 0.800 |
COT |
0.723 | 0.021 | 2 | 0.791 |
DYRK3 |
0.722 | 0.410 | 1 | 0.721 |
SRPK3 |
0.715 | 0.192 | -3 | 0.676 |
MOS |
0.715 | 0.099 | 1 | 0.279 |
ICK |
0.715 | 0.267 | -3 | 0.795 |
CDKL5 |
0.713 | 0.124 | -3 | 0.750 |
CDKL1 |
0.708 | 0.102 | -3 | 0.756 |
ERK7 |
0.707 | 0.236 | 2 | 0.570 |
MOK |
0.707 | 0.347 | 1 | 0.649 |
CDC7 |
0.707 | -0.054 | 1 | 0.240 |
PRKD1 |
0.706 | 0.078 | -3 | 0.791 |
PRPK |
0.703 | -0.026 | -1 | 0.752 |
CHAK2 |
0.702 | -0.002 | -1 | 0.744 |
NEK6 |
0.702 | -0.007 | -2 | 0.746 |
MST4 |
0.701 | -0.026 | 2 | 0.818 |
DSTYK |
0.700 | -0.077 | 2 | 0.840 |
GRK1 |
0.700 | 0.015 | -2 | 0.697 |
PRKD2 |
0.700 | 0.052 | -3 | 0.726 |
SKMLCK |
0.700 | 0.028 | -2 | 0.772 |
PIM3 |
0.700 | -0.036 | -3 | 0.799 |
GCN2 |
0.699 | -0.101 | 2 | 0.715 |
NDR2 |
0.699 | -0.035 | -3 | 0.799 |
ATR |
0.699 | -0.026 | 1 | 0.258 |
AURC |
0.699 | 0.029 | -2 | 0.564 |
TBK1 |
0.699 | -0.107 | 1 | 0.192 |
IKKB |
0.699 | -0.104 | -2 | 0.636 |
IKKE |
0.697 | -0.105 | 1 | 0.191 |
PKCD |
0.695 | 0.005 | 2 | 0.742 |
BMPR1B |
0.695 | 0.006 | 1 | 0.220 |
RAF1 |
0.695 | -0.140 | 1 | 0.223 |
PKCB |
0.695 | 0.014 | 2 | 0.726 |
MLK3 |
0.694 | 0.009 | 2 | 0.727 |
BMPR2 |
0.694 | -0.094 | -2 | 0.752 |
ULK2 |
0.694 | -0.120 | 2 | 0.704 |
MPSK1 |
0.694 | 0.126 | 1 | 0.283 |
GRK7 |
0.693 | 0.018 | 1 | 0.249 |
PKN3 |
0.693 | -0.031 | -3 | 0.782 |
WNK1 |
0.693 | -0.066 | -2 | 0.779 |
MLK2 |
0.693 | -0.001 | 2 | 0.779 |
PKN2 |
0.693 | -0.043 | -3 | 0.785 |
IKKA |
0.693 | -0.051 | -2 | 0.642 |
PKCA |
0.692 | 0.023 | 2 | 0.716 |
TGFBR2 |
0.692 | -0.067 | -2 | 0.670 |
NUAK2 |
0.691 | -0.020 | -3 | 0.792 |
NIK |
0.691 | -0.029 | -3 | 0.826 |
NDR1 |
0.691 | -0.066 | -3 | 0.784 |
MLK1 |
0.691 | -0.108 | 2 | 0.776 |
CAMK1B |
0.690 | -0.046 | -3 | 0.803 |
NEK7 |
0.690 | -0.128 | -3 | 0.805 |
MAPKAPK3 |
0.689 | -0.007 | -3 | 0.735 |
PDHK4 |
0.689 | -0.192 | 1 | 0.282 |
PKCG |
0.688 | -0.018 | 2 | 0.715 |
PIM1 |
0.688 | -0.008 | -3 | 0.740 |
GRK5 |
0.688 | -0.100 | -3 | 0.833 |
MAPKAPK2 |
0.688 | 0.005 | -3 | 0.693 |
RSK2 |
0.688 | -0.025 | -3 | 0.720 |
GSK3A |
0.688 | 0.145 | 4 | 0.328 |
MNK2 |
0.688 | -0.001 | -2 | 0.681 |
IRE1 |
0.687 | -0.074 | 1 | 0.204 |
CAMLCK |
0.687 | -0.019 | -2 | 0.729 |
RSK3 |
0.686 | -0.035 | -3 | 0.717 |
PHKG1 |
0.686 | -0.032 | -3 | 0.778 |
PKCZ |
0.685 | -0.019 | 2 | 0.748 |
NEK9 |
0.685 | -0.096 | 2 | 0.786 |
MARK4 |
0.685 | -0.056 | 4 | 0.706 |
PDHK1 |
0.684 | -0.168 | 1 | 0.257 |
PKACB |
0.684 | 0.016 | -2 | 0.575 |
DAPK2 |
0.683 | -0.037 | -3 | 0.814 |
P90RSK |
0.683 | -0.029 | -3 | 0.728 |
RIPK3 |
0.683 | -0.148 | 3 | 0.598 |
PKACG |
0.683 | -0.049 | -2 | 0.634 |
TGFBR1 |
0.683 | -0.018 | -2 | 0.690 |
CAMK2G |
0.682 | -0.126 | 2 | 0.691 |
MST3 |
0.682 | 0.018 | 2 | 0.822 |
ULK1 |
0.681 | -0.139 | -3 | 0.780 |
BCKDK |
0.681 | -0.132 | -1 | 0.678 |
PRKD3 |
0.681 | 0.002 | -3 | 0.687 |
LATS2 |
0.680 | -0.073 | -5 | 0.433 |
PAK6 |
0.680 | 0.014 | -2 | 0.581 |
CK1E |
0.680 | 0.019 | -3 | 0.585 |
CAMK2D |
0.679 | -0.066 | -3 | 0.793 |
NEK2 |
0.679 | -0.047 | 2 | 0.779 |
AMPKA1 |
0.679 | -0.082 | -3 | 0.807 |
AKT2 |
0.679 | 0.018 | -3 | 0.637 |
HUNK |
0.679 | -0.143 | 2 | 0.729 |
PKR |
0.679 | -0.060 | 1 | 0.234 |
YSK4 |
0.679 | -0.076 | 1 | 0.203 |
ALK4 |
0.679 | -0.040 | -2 | 0.713 |
MLK4 |
0.678 | -0.064 | 2 | 0.687 |
MASTL |
0.678 | -0.132 | -2 | 0.689 |
P70S6KB |
0.678 | -0.049 | -3 | 0.737 |
SGK3 |
0.677 | -0.007 | -3 | 0.720 |
PAK1 |
0.677 | -0.044 | -2 | 0.667 |
NIM1 |
0.677 | -0.075 | 3 | 0.626 |
LATS1 |
0.677 | -0.031 | -3 | 0.808 |
TTBK2 |
0.677 | -0.134 | 2 | 0.647 |
MNK1 |
0.677 | -0.026 | -2 | 0.690 |
DNAPK |
0.677 | -0.034 | 1 | 0.224 |
PINK1 |
0.676 | 0.106 | 1 | 0.425 |
BUB1 |
0.676 | 0.109 | -5 | 0.475 |
TSSK1 |
0.676 | -0.047 | -3 | 0.825 |
ACVR2B |
0.676 | -0.051 | -2 | 0.679 |
SMG1 |
0.676 | -0.056 | 1 | 0.235 |
VRK2 |
0.676 | 0.041 | 1 | 0.313 |
DLK |
0.676 | -0.172 | 1 | 0.231 |
PKG2 |
0.676 | -0.021 | -2 | 0.578 |
TAO3 |
0.676 | 0.004 | 1 | 0.249 |
TLK2 |
0.675 | -0.046 | 1 | 0.191 |
CHAK1 |
0.675 | -0.102 | 2 | 0.754 |
ANKRD3 |
0.675 | -0.143 | 1 | 0.233 |
TSSK2 |
0.675 | -0.063 | -5 | 0.492 |
FAM20C |
0.675 | -0.024 | 2 | 0.570 |
PKCH |
0.675 | -0.060 | 2 | 0.695 |
PAK3 |
0.675 | -0.062 | -2 | 0.659 |
AMPKA2 |
0.675 | -0.066 | -3 | 0.770 |
QSK |
0.674 | -0.039 | 4 | 0.695 |
IRE2 |
0.674 | -0.093 | 2 | 0.675 |
CK1D |
0.673 | 0.039 | -3 | 0.537 |
GRK6 |
0.673 | -0.141 | 1 | 0.226 |
GRK4 |
0.673 | -0.132 | -2 | 0.723 |
RSK4 |
0.673 | -0.040 | -3 | 0.694 |
ACVR2A |
0.673 | -0.074 | -2 | 0.662 |
PRKX |
0.672 | -0.007 | -3 | 0.637 |
ATM |
0.672 | -0.089 | 1 | 0.215 |
MEK1 |
0.671 | -0.103 | 2 | 0.753 |
RIPK1 |
0.671 | -0.203 | 1 | 0.202 |
LKB1 |
0.671 | 0.108 | -3 | 0.809 |
PKCT |
0.671 | -0.038 | 2 | 0.699 |
AURB |
0.671 | -0.036 | -2 | 0.554 |
NEK5 |
0.670 | -0.027 | 1 | 0.208 |
CAMK2A |
0.669 | -0.044 | 2 | 0.690 |
TNIK |
0.669 | 0.060 | 3 | 0.786 |
WNK3 |
0.669 | -0.257 | 1 | 0.210 |
MEKK2 |
0.669 | -0.064 | 2 | 0.742 |
PIM2 |
0.668 | -0.020 | -3 | 0.692 |
QIK |
0.668 | -0.116 | -3 | 0.783 |
MEKK1 |
0.668 | -0.088 | 1 | 0.219 |
GRK2 |
0.667 | -0.070 | -2 | 0.634 |
SIK |
0.667 | -0.054 | -3 | 0.708 |
PKCE |
0.667 | -0.009 | 2 | 0.713 |
ALK2 |
0.667 | -0.075 | -2 | 0.692 |
NUAK1 |
0.667 | -0.078 | -3 | 0.726 |
ZAK |
0.666 | -0.108 | 1 | 0.204 |
PKCI |
0.666 | -0.035 | 2 | 0.719 |
MSK2 |
0.666 | -0.067 | -3 | 0.707 |
CK1A2 |
0.666 | 0.013 | -3 | 0.535 |
GCK |
0.666 | 0.000 | 1 | 0.240 |
PLK4 |
0.666 | -0.106 | 2 | 0.503 |
BMPR1A |
0.666 | -0.058 | 1 | 0.207 |
MARK3 |
0.666 | -0.048 | 4 | 0.644 |
MEK5 |
0.665 | -0.121 | 2 | 0.754 |
GSK3B |
0.665 | 0.016 | 4 | 0.324 |
CK1G1 |
0.665 | -0.021 | -3 | 0.561 |
DCAMKL1 |
0.665 | -0.043 | -3 | 0.738 |
NEK11 |
0.665 | -0.069 | 1 | 0.243 |
AKT1 |
0.665 | -0.009 | -3 | 0.658 |
DRAK1 |
0.665 | -0.121 | 1 | 0.209 |
HPK1 |
0.665 | -0.002 | 1 | 0.241 |
PERK |
0.665 | -0.105 | -2 | 0.702 |
MELK |
0.664 | -0.093 | -3 | 0.747 |
CAMK2B |
0.664 | -0.086 | 2 | 0.667 |
KHS1 |
0.664 | 0.041 | 1 | 0.222 |
HGK |
0.663 | 0.006 | 3 | 0.777 |
MAP3K15 |
0.663 | -0.003 | 1 | 0.212 |
HASPIN |
0.663 | 0.044 | -1 | 0.654 |
CAMK4 |
0.663 | -0.143 | -3 | 0.764 |
MSK1 |
0.662 | -0.051 | -3 | 0.708 |
KHS2 |
0.662 | 0.027 | 1 | 0.241 |
PLK1 |
0.662 | -0.161 | -2 | 0.660 |
IRAK4 |
0.662 | -0.109 | 1 | 0.184 |
MYLK4 |
0.662 | -0.069 | -2 | 0.663 |
AKT3 |
0.662 | 0.020 | -3 | 0.588 |
MEKK6 |
0.662 | -0.023 | 1 | 0.216 |
PKACA |
0.661 | -0.017 | -2 | 0.537 |
GAK |
0.661 | -0.036 | 1 | 0.290 |
MEKK3 |
0.661 | -0.167 | 1 | 0.223 |
PDK1 |
0.660 | -0.026 | 1 | 0.245 |
PASK |
0.660 | -0.056 | -3 | 0.821 |
BRSK1 |
0.660 | -0.081 | -3 | 0.739 |
MAPKAPK5 |
0.660 | -0.079 | -3 | 0.678 |
TAO2 |
0.660 | -0.039 | 2 | 0.798 |
AURA |
0.660 | -0.057 | -2 | 0.533 |
PAK2 |
0.659 | -0.099 | -2 | 0.641 |
BRSK2 |
0.659 | -0.104 | -3 | 0.759 |
WNK4 |
0.659 | -0.134 | -2 | 0.768 |
MINK |
0.659 | -0.043 | 1 | 0.207 |
PAK5 |
0.659 | -0.034 | -2 | 0.519 |
CHK1 |
0.658 | -0.095 | -3 | 0.786 |
MARK2 |
0.658 | -0.078 | 4 | 0.613 |
TLK1 |
0.658 | -0.104 | -2 | 0.730 |
BRAF |
0.658 | -0.096 | -4 | 0.756 |
NEK4 |
0.658 | -0.055 | 1 | 0.198 |
PBK |
0.658 | 0.011 | 1 | 0.259 |
LOK |
0.657 | -0.014 | -2 | 0.643 |
HRI |
0.657 | -0.158 | -2 | 0.717 |
MST2 |
0.657 | -0.054 | 1 | 0.216 |
PAK4 |
0.657 | -0.019 | -2 | 0.528 |
PHKG2 |
0.655 | -0.107 | -3 | 0.729 |
NEK8 |
0.655 | -0.115 | 2 | 0.765 |
GRK3 |
0.654 | -0.076 | -2 | 0.605 |
PKN1 |
0.654 | -0.039 | -3 | 0.670 |
SSTK |
0.654 | -0.061 | 4 | 0.679 |
CAMKK2 |
0.654 | -0.047 | -2 | 0.631 |
DCAMKL2 |
0.654 | -0.072 | -3 | 0.748 |
SLK |
0.654 | -0.035 | -2 | 0.599 |
CAMK1G |
0.653 | -0.095 | -3 | 0.697 |
NEK1 |
0.652 | -0.030 | 1 | 0.191 |
CK2A2 |
0.652 | -0.069 | 1 | 0.205 |
SGK1 |
0.652 | 0.005 | -3 | 0.568 |
PLK3 |
0.652 | -0.142 | 2 | 0.652 |
CAMKK1 |
0.652 | -0.113 | -2 | 0.630 |
EEF2K |
0.651 | -0.062 | 3 | 0.720 |
LRRK2 |
0.650 | -0.032 | 2 | 0.783 |
YSK1 |
0.650 | -0.047 | 2 | 0.781 |
SNRK |
0.650 | -0.174 | 2 | 0.575 |
SBK |
0.650 | 0.077 | -3 | 0.522 |
MARK1 |
0.649 | -0.110 | 4 | 0.657 |
SMMLCK |
0.649 | -0.085 | -3 | 0.756 |
OSR1 |
0.648 | 0.001 | 2 | 0.743 |
ROCK2 |
0.648 | -0.022 | -3 | 0.740 |
TAK1 |
0.647 | -0.100 | 1 | 0.204 |
MST1 |
0.647 | -0.066 | 1 | 0.205 |
P70S6K |
0.645 | -0.082 | -3 | 0.651 |
MYO3B |
0.644 | 0.010 | 2 | 0.794 |
AAK1 |
0.644 | 0.032 | 1 | 0.273 |
MRCKB |
0.644 | -0.035 | -3 | 0.677 |
CHK2 |
0.644 | -0.034 | -3 | 0.585 |
DAPK3 |
0.644 | -0.065 | -3 | 0.746 |
CK2A1 |
0.643 | -0.077 | 1 | 0.199 |
NEK3 |
0.643 | -0.065 | 1 | 0.204 |
BIKE |
0.642 | -0.007 | 1 | 0.274 |
TTBK1 |
0.642 | -0.170 | 2 | 0.554 |
CK1A |
0.641 | 0.005 | -3 | 0.451 |
STK33 |
0.640 | -0.112 | 2 | 0.536 |
VRK1 |
0.640 | -0.140 | 2 | 0.748 |
PDHK3_TYR |
0.639 | 0.140 | 4 | 0.751 |
LIMK2_TYR |
0.638 | 0.158 | -3 | 0.843 |
CAMK1D |
0.638 | -0.070 | -3 | 0.631 |
TAO1 |
0.637 | -0.045 | 1 | 0.203 |
DAPK1 |
0.637 | -0.074 | -3 | 0.730 |
IRAK1 |
0.636 | -0.234 | -1 | 0.652 |
ASK1 |
0.636 | -0.033 | 1 | 0.211 |
DMPK1 |
0.635 | -0.022 | -3 | 0.697 |
MYO3A |
0.635 | -0.044 | 1 | 0.220 |
TESK1_TYR |
0.635 | 0.097 | 3 | 0.760 |
CAMK1A |
0.634 | -0.037 | -3 | 0.599 |
PKMYT1_TYR |
0.634 | 0.113 | 3 | 0.730 |
MEK2 |
0.634 | -0.146 | 2 | 0.726 |
MAP2K4_TYR |
0.633 | 0.105 | -1 | 0.761 |
PLK2 |
0.633 | -0.081 | -3 | 0.778 |
TTK |
0.633 | -0.069 | -2 | 0.687 |
PDHK4_TYR |
0.632 | 0.057 | 2 | 0.782 |
MRCKA |
0.631 | -0.077 | -3 | 0.694 |
CRIK |
0.631 | -0.031 | -3 | 0.663 |
ROCK1 |
0.630 | -0.047 | -3 | 0.696 |
MAP2K6_TYR |
0.630 | 0.055 | -1 | 0.776 |
BMPR2_TYR |
0.630 | 0.052 | -1 | 0.801 |
PKG1 |
0.629 | -0.062 | -2 | 0.497 |
PDHK1_TYR |
0.626 | 0.002 | -1 | 0.775 |
MAP2K7_TYR |
0.624 | -0.058 | 2 | 0.768 |
ABL2 |
0.623 | 0.026 | -1 | 0.669 |
RIPK2 |
0.623 | -0.236 | 1 | 0.184 |
YANK3 |
0.623 | -0.059 | 2 | 0.332 |
TXK |
0.622 | 0.005 | 1 | 0.215 |
PINK1_TYR |
0.622 | -0.104 | 1 | 0.272 |
CSF1R |
0.622 | -0.007 | 3 | 0.695 |
LIMK1_TYR |
0.620 | -0.011 | 2 | 0.778 |
JAK2 |
0.620 | -0.017 | 1 | 0.229 |
EPHA6 |
0.620 | -0.014 | -1 | 0.742 |
LCK |
0.620 | 0.003 | -1 | 0.740 |
RET |
0.619 | -0.066 | 1 | 0.226 |
ABL1 |
0.619 | 0.009 | -1 | 0.660 |
ALPHAK3 |
0.618 | -0.090 | -1 | 0.668 |
BLK |
0.617 | -0.012 | -1 | 0.738 |
MST1R |
0.617 | -0.053 | 3 | 0.711 |
JAK1 |
0.616 | -0.023 | 1 | 0.198 |
TNNI3K_TYR |
0.616 | 0.012 | 1 | 0.233 |
EPHB4 |
0.614 | -0.031 | -1 | 0.672 |
NEK10_TYR |
0.614 | -0.055 | 1 | 0.205 |
FGR |
0.614 | -0.081 | 1 | 0.219 |
ROS1 |
0.614 | -0.085 | 3 | 0.656 |
TYK2 |
0.613 | -0.140 | 1 | 0.210 |
TYRO3 |
0.613 | -0.093 | 3 | 0.696 |
STLK3 |
0.612 | -0.133 | 1 | 0.186 |
JAK3 |
0.612 | -0.077 | 1 | 0.216 |
HCK |
0.612 | -0.061 | -1 | 0.723 |
TNK2 |
0.612 | -0.048 | 3 | 0.652 |
MET |
0.610 | -0.029 | 3 | 0.693 |
TNK1 |
0.610 | -0.032 | 3 | 0.680 |
YES1 |
0.610 | -0.082 | -1 | 0.708 |
KDR |
0.609 | -0.051 | 3 | 0.640 |
ITK |
0.609 | -0.084 | -1 | 0.680 |
KIT |
0.608 | -0.067 | 3 | 0.688 |
FYN |
0.607 | -0.021 | -1 | 0.738 |
FGFR2 |
0.603 | -0.066 | 3 | 0.653 |
ZAP70 |
0.602 | 0.030 | -1 | 0.651 |
EPHA4 |
0.602 | -0.058 | 2 | 0.666 |
FER |
0.601 | -0.151 | 1 | 0.223 |
SRMS |
0.601 | -0.112 | 1 | 0.201 |
BMX |
0.601 | -0.075 | -1 | 0.604 |
INSRR |
0.601 | -0.135 | 3 | 0.613 |
CK1G3 |
0.600 | -0.043 | -3 | 0.404 |
MERTK |
0.600 | -0.091 | 3 | 0.665 |
DDR1 |
0.600 | -0.160 | 4 | 0.661 |
WEE1_TYR |
0.599 | -0.085 | -1 | 0.624 |
TEK |
0.599 | -0.051 | 3 | 0.616 |
FLT1 |
0.599 | -0.079 | -1 | 0.713 |
FGFR1 |
0.599 | -0.071 | 3 | 0.635 |
PTK2 |
0.598 | 0.004 | -1 | 0.745 |
EPHB3 |
0.598 | -0.092 | -1 | 0.653 |
FLT3 |
0.598 | -0.164 | 3 | 0.700 |
PDGFRB |
0.597 | -0.175 | 3 | 0.691 |
EPHB2 |
0.597 | -0.088 | -1 | 0.646 |
EPHB1 |
0.597 | -0.135 | 1 | 0.198 |
FRK |
0.596 | -0.086 | -1 | 0.712 |
CK1G2 |
0.596 | -0.034 | -3 | 0.487 |
SYK |
0.596 | -0.012 | -1 | 0.704 |
AXL |
0.595 | -0.130 | 3 | 0.654 |
FGFR3 |
0.594 | -0.072 | 3 | 0.622 |
LYN |
0.594 | -0.089 | 3 | 0.604 |
YANK2 |
0.594 | -0.071 | 2 | 0.352 |
SRC |
0.593 | -0.074 | -1 | 0.703 |
ERBB2 |
0.592 | -0.121 | 1 | 0.204 |
EPHA1 |
0.592 | -0.090 | 3 | 0.677 |
MATK |
0.592 | -0.073 | -1 | 0.598 |
TEC |
0.592 | -0.133 | -1 | 0.584 |
PDGFRA |
0.591 | -0.181 | 3 | 0.699 |
EPHA7 |
0.591 | -0.089 | 2 | 0.669 |
EGFR |
0.591 | -0.079 | 1 | 0.171 |
BTK |
0.590 | -0.190 | -1 | 0.629 |
PTK2B |
0.590 | -0.066 | -1 | 0.623 |
EPHA8 |
0.590 | -0.060 | -1 | 0.679 |
ALK |
0.589 | -0.138 | 3 | 0.602 |
NTRK3 |
0.589 | -0.099 | -1 | 0.609 |
DDR2 |
0.587 | -0.073 | 3 | 0.596 |
ERBB4 |
0.586 | -0.051 | 1 | 0.182 |
EPHA3 |
0.585 | -0.107 | 2 | 0.633 |
FGFR4 |
0.585 | -0.075 | -1 | 0.613 |
INSR |
0.584 | -0.160 | 3 | 0.600 |
PTK6 |
0.584 | -0.162 | -1 | 0.587 |
CSK |
0.583 | -0.112 | 2 | 0.667 |
FLT4 |
0.583 | -0.163 | 3 | 0.617 |
LTK |
0.583 | -0.159 | 3 | 0.621 |
MUSK |
0.583 | -0.103 | 1 | 0.159 |
NTRK1 |
0.582 | -0.192 | -1 | 0.653 |
NTRK2 |
0.580 | -0.200 | 3 | 0.629 |
EPHA5 |
0.579 | -0.117 | 2 | 0.641 |
EPHA2 |
0.578 | -0.077 | -1 | 0.642 |
IGF1R |
0.570 | -0.138 | 3 | 0.534 |
FES |
0.558 | -0.143 | -1 | 0.570 |